<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Lens extraction for chronic angle‐closure glaucoma - Ong, AY - 2021 | Cochrane Library</title> <meta content="Lens extraction for chronic angle‐closure glaucoma - Ong, AY - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005555.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Lens extraction for chronic angle‐closure glaucoma - Ong, AY - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005555.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005555.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Lens extraction for chronic angle‐closure glaucoma" name="citation_title"/> <meta content="Ariel Yuhan Ong" name="citation_author"/> <meta content="Oxford University Hospitals NHS Foundation Trust" name="citation_author_institution"/> <meta content="ariel.ong@nhs.net" name="citation_author_email"/> <meta content="Sueko M Ng" name="citation_author"/> <meta content="University of Colorado" name="citation_author_institution"/> <meta content="S Swaroop Vedula" name="citation_author"/> <meta content="Johns Hopkins University" name="citation_author_institution"/> <meta content="David S. Friedman" name="citation_author"/> <meta content="Harvard Medical School" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD005555.pub3" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/03/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005555.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005555.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005555.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Chronic Disease; Disease Progression; Glaucoma, Angle-Closure [drug therapy, *surgery]; Lens, Crystalline [*surgery]; Phacoemulsification [adverse effects, *methods]; Quality of Life; Randomized Controlled Trials as Topic; Visual Acuity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005555.pub3&amp;doi=10.1002/14651858.CD005555.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="KUoIaN9D";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005555\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005555\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ru","ko","th","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005555.pub3",title:"Lens extraction for chronic angle\\u2010closure glaucoma",firstPublishedDate:"Mar 24, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=KUoIaN9D&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005555.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005555.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005555.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005555.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005555.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005555.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005555.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005555.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005555.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005555.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>3392 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005555.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-sec-0112"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-sec-0016"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-sec-0017"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-sec-0044"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-sec-0106"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/appendices#CD005555-sec-0117"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/supinfo/CD005555StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/supinfo/CD005555StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Lens extraction for chronic angle‐closure glaucoma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information#CD005555-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Ariel Yuhan Ong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information#CD005555-cr-0005">Sueko M Ng</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information#CD005555-cr-0006">S Swaroop Vedula</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information#CD005555-cr-0007">David S. Friedman</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information/en#CD005555-sec-0127">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 March 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005555.pub3">https://doi.org/10.1002/14651858.CD005555.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005555-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005555-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005555-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005555-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005555-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005555-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD005555-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005555-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005555-abs-0001" lang="en"> <section id="CD005555-sec-0001"> <h3 class="title" id="CD005555-sec-0001">Background</h3> <p>Primary angle‐closure glaucoma (PACG) is characterized by a rise in intraocular pressure (IOP) secondary to aqueous outflow obstruction, with relative pupillary block being the most common underlying mechanism. There is increasing evidence that lens extraction may relieve pupillary block and thereby improve IOP control. As such, comparing the effectiveness of lens extraction against other commonly used treatment modalities can help inform the decision‐making process. </p> </section> <section id="CD005555-sec-0002"> <h3 class="title" id="CD005555-sec-0002">Objectives</h3> <p>To assess the effectiveness of lens extraction compared with other interventions in the treatment of chronic PACG in people without previous acute angle‐closure attacks. </p> </section> <section id="CD005555-sec-0003"> <h3 class="title" id="CD005555-sec-0003">Search methods</h3> <p>We searched CENTRAL, MEDLINE, Embase, one other database, and two trials registers (December 2019). We also screened the reference lists of included studies and the Science Citation Index database. We had no date or language restrictions. </p> </section> <section id="CD005555-sec-0004"> <h3 class="title" id="CD005555-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) comparing lens extraction with other treatment modalities for chronic PACG. </p> </section> <section id="CD005555-sec-0005"> <h3 class="title" id="CD005555-sec-0005">Data collection and analysis</h3> <p>We followed standard Cochrane methodology.</p> </section> <section id="CD005555-sec-0006"> <h3 class="title" id="CD005555-sec-0006">Main results</h3> <p>We identified eight RCTs with 914 eyes. We obtained data for participants meeting our inclusion criteria for these studies (PACG only, no previous acute angle‐closure attacks), resulting in 513 eyes included in this review. The participants were recruited from a diverse range of countries. We were unable to conduct meta‐analyses due to different follow‐up periods and insufficient data. </p> <p>One study compared phacoemulsification with laser peripheral iridotomy (LPI) as standard care. Participants in the phacoemulsification group were less likely to experience progression of visual field loss (odds ratio [OR] 0.35, 95% confidence interval [CI] 0.13 to 0.91; 216 eyes; moderate certainty evidence), and required fewer IOP‐lowering medications (mean difference [MD] ‐0.70, 95% CI ‐0.89 to ‐0.51; 263 eyes; moderate certainty evidence) compared with standard care at 12 months. Moderate certainty evidence also suggested that phacoemulsification improved gonioscopic findings at 12 months or later (MD ‐84.93, 95% CI ‐131.25 to ‐38.61; 106 eyes). There was little to no difference in health‐related quality of life measures (MD 0.04, 95% CI ‐0.16 to 0.24; 254 eyes; moderate certainty evidence), and visual acuity (VA) (MD 2.03 ETDRS letter, 95% CI ‐0.77 to 4.84; 242 eyes) at 12 months, and no observable difference in mean IOP (MD ‐0.03mmHg, 95% CI ‐2.34 to 2.32; 257 eyes; moderate certainty evidence) compared to standard care. Irreversible loss of vision was observed in one participant in the phacoemulsification group, and three participants in standard care at 36 months (moderate‐certainty evidence). </p> <p>One study (91 eyes) compared phacoemulsification with phaco‐viscogonioplasty (phaco‐VGP). Low‐certainty evidence suggested that fewer IOP‐lowering medications were needed at 12 months with phacoemulsification (MD ‐0.30, 95% CI ‐0.55 to ‐0.05). Low‐certainty evidence also suggested that phacoemulsification may have improved gonioscopic findings at 12 months or later compared to phaco‐VGP (angle grading MD ‐0.60, 95% CI ‐0.91 to ‐0.29; TISA500 MD ‐0.03, 95% CI ‐0.06 to ‐0.01; TISA750 MD ‐0.03, 95% CI ‐0.06 to ‐0.01; 91 eyes). Phacoemulsification may result in little to no difference in best corrected VA at 12 months (MD ‐0.01 log MAR units, 95% CI ‐0.10 to 0.08; low certainty evidence), and the evidence is very uncertain about its effect on IOP at 12 months (MD 0.50 mmHg, 95% CI ‐2.64 to 3.64; very low certainty evidence). Postoperative fibrin reaction was observed in two participants in the phacoemulsification group and four in the phaco‐VGP group. Three participants in the phaco‐VGP group experienced hyphema. No data were available for progression of visual field loss and quality of life measurements at 12 months. </p> <p>Two studies compared phacoemulsification with phaco‐goniosynechialysis (phaco‐GSL). Low‐certainty evidence suggested that there may be little to no difference in mean IOP at 12 months (MD ‐0.12 mmHg, 95% CI ‐4.72 to 4.48; 1 study, 32 eyes) between the interventions. Phacoemulsification did not reduce the number of IOP‐lowering medications compared to phaco‐GSL at 12 months (MD ‐0.38, 95% CI ‐1.23 to 0.47; 1 study, 32 eyes; moderate certainty evidence). Three eyes in the phaco‐GSL group developed hyphemas. No data were available at 12 months for progression of visual field loss, gonioscopic findings, visual acuity, and quality of life measures. </p> <p>Three studies compared phacoemulsification with combined phaco‐trabeculectomy, but the data were only available for one study (63 eyes). In this study, low‐certainty evidence suggested that there was little to no difference between groups in mean change in IOP from baseline (MD ‐0.60 mmHg, 95% CI ‐1.99 to 0.79), number of IOP‐lowering medications at 12 months (MD 0.00, 95% CI ‐0.42 to 0.42), and VA measured by the Snellen chart (MD ‐0.03, 95% CI ‐0.18 to 0.12). Participants in the phacoemulsification group had fewer complications (risk ratio [RR] 0.59, 95% CI 0.34 to 1.04), and the phaco‐trabeculectomy group required more IOP‐lowering procedures (RR 5.81, 95% CI 1.41 to 23.88), but the evidence was very uncertain. No data were available for other outcomes. </p> </section> <section id="CD005555-sec-0007"> <h3 class="title" id="CD005555-sec-0007">Authors' conclusions</h3> <p>Moderate certainty evidence showed that lens extraction has an advantage over LPI in treating chronic PACG with clear crystalline lenses over three years of follow‐up; ultimately, the decision for intervention should be part of a shared decision‐making process between the clinician and the patient. For people with chronic PACG and visually significant cataracts, low certainty evidence suggested that combining phacoemulsification with either viscogonioplasty or goniosynechialysis does not confer any additional benefit over phacoemulsification alone. There was insufficient evidence to draw any meaningful conclusions regarding phacoemulsification versus trabeculectomy. Low certainty evidence suggested that combining phacoemulsification with trabeculectomy does not confer any additional benefit over phacoemulsification alone, and may cause more complications instead. These conclusions only apply to short‐ to medium‐term outcomes; studies with longer follow‐up periods can help assess whether these effects persist in the long term. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005555-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005555-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005555-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005555-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005555-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005555-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005555-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005555-abs-0011">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005555-abs-0006">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD005555-abs-0010">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005555-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD005555-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005555-abs-0002" lang="en"> <h3>What are the benefits and risks of lens extraction in treating chronic primary angle‐closure glaucoma? </h3> <p><b>Why is this question important?</b><br/>Primary angle‐closure glaucoma (PACG) is a type of glaucoma which is one of the leading causes of blindness worldwide. It occurs when there are problems with fluid drainage from the eye because the iris (the colored part of the eye) has blocked the drainage channels. A blockage can happen suddenly (acute PACG) or gradually (chronic PACG), causing a build‐up of fluid and raising the pressure inside the eye, which can damage the optic nerve and lead to vision loss. Treatment options include eye drops, laser treatment, and surgery. 'Lens extraction' is a type of surgery where the natural lens is replaced with an artificial lens. This also has the effect of opening up the drainage channels and may help to treat PACG. We reviewed the research evidence to find out how lens extraction compares to other treatments for chronic PACG. </p> <p><b>How did we identify and evaluate the evidence?</b><br/>We searched the medical literature for studies that compared lens extraction with other treatments for chronic PACG, compared the results and summarized the evidence from all the studies, and rated our confidence in the evidence. </p> <p><b>What did we find?</b><br/>We found eight studies comprising 513 eyes with chronic PACG that met our inclusion criteria. The studies followed participants for six to 69 months, and compared lens extraction against: </p> <p>‐ laser therapy;<br/>‐ lens extraction plus an injection of thick liquid to break iris adhesions with the aim of encouraging fluid outflow (viscogonioplasty, VGP);<br/>‐ lens extraction plus breaking the iris adhesions mechanically, known as goniosynechialysis (GSL);<br/>‐ trabeculectomy (creating a flap to facilitate fluid drainage); and<br/>‐ lens extraction plus trabeculectomy. </p> <p>These are the main findings of our review, focusing on results one year after treatment (unless otherwise stated). </p> <p><i>1. Lens extraction compared with laser therapy (1 study)</i> </p> <p>When compared against laser therapy, the evidence suggests that lens extraction probably:</p> <p>‐ limits loss of visual field (the area that can be seen when the eye is looking straight ahead);<br/>‐ reduces the number of pressure‐lowering medicines needed;<br/>‐ open the drainage angle more; and<br/>‐ makes little or no difference to quality of life, vision clarity, or eye pressure. </p> <p>One person treated with lens extraction, and three people treated with laser therapy, experienced irreversible loss of 10 or more EDTRS letters of vision in the three years after treatment. </p> <p><i>2. Lens extraction compared with lens extraction plus VGP (1 study)</i> </p> <p>When compared against lens extraction plus VGP, the evidence suggests that lens extraction may: </p> <p>‐ reduce the number of pressure‐lowering medications needed;<br/>‐ open the drainage angle more; and<br/>‐ make little or no difference to clarity of vision. </p> <p>There is uncertain evidence as to whether the two treatments have different effects on eye pressure. The study did not investigate the effects on visual field loss and quality of life. </p> <p>Eye inflammation occurred in two people treated with lens extraction, and in four people treated with lens extraction plus VGP. Three people treated with lens extraction plus VGP experienced bleeding in the front of the eye. </p> <p><i>3. Lens extraction compared with lens extraction plus GSL (2 studies)</i> </p> <p>When compared against lens extraction plus GSL, the evidence suggests that lens extraction:</p> <p>‐ probably does not reduce the number of pressure‐lowering medications needed; and<br/>‐ may make little or no difference to eye pressure. </p> <p>The studies did not investigate the effects on visual field loss, eye drainage, vision clarity, and quality of life. </p> <p>Bleeding in the front of the eye occurred in three eyes treated with lens extraction plus GSL. </p> <p><i>4. Lens extraction compared with lens extraction plus trabeculectomy (3 studies)</i> </p> <p>When compared against lens extraction plus trabeculectomy, the evidence from one study suggests that lens extraction may make little or no difference to: </p> <p>‐ eye pressure;<br/>‐ the number of pressure‐lowering medications needed; and<br/>‐ vision clarity. </p> <p>There is uncertain evidence as to whether one treatment leads to more unwanted effects than the other. The studies did not investigate the effects on visual field loss, eye drainage, and quality of life. </p> <p><b>What does this mean?</b><br/>The evidence suggests that: </p> <p>‐ lens extraction is probably a better treatment than laser therapy for chronic PACG;<br/>‐ combining lens extraction with VGP or GSL may not work better than lens extraction alone; and<br/>‐ there is uncertain evidence as to whether combining lens extraction with trabeculectomy makes a difference. </p> <p><b>How‐up‐to date is this review?</b><br/>The evidence in this Cochrane Review is current to 13 December 2019. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005555-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005555-sec-0112"></div> <h3 class="title" id="CD005555-sec-0113">Implications for practice</h3> <section id="CD005555-sec-0113"> <p>Moderate quality evidence suggests that lens extraction is preferable to standard care in treating patients with chronic primary angle closure glaucoma (PACG) and clear crystalline lenses. These findings are potentially practice‐changing, but should ultimately be part of a shared decision‐making process between the clinician and the patient, taking into account their preferences, health status, and visual prognosis. </p> <p>For patients with visually significant cataracts, low quality evidence suggests that combining phacoemulsification with either goniosynechialysis (GSL) or viscogonioplasty (VGP) does not appear to confer any additional benefit over phacoemulsification alone. </p> <p>We found insufficient evidence to draw any meaningful conclusions regarding phacoemulsification versus trabeculectomy. In addition, low‐quality evidence suggests that combining phacoemulsification with trabeculectomy does not confer any additional clinical benefit over phacoemulsification alone, and may perhaps lead to more complications. This suggests that combined phaco‐trabeculectomy may not be the best course of action for chronic PACG in the first instance. Whether a two‐step procedure is beneficial and when to undertake this may be of interest, but is not within the scope of the review. </p> </section> <h3 class="title" id="CD005555-sec-0114">Implications for research</h3> <section id="CD005555-sec-0114"> <p>Studies with longer follow‐up periods (over five years) will help to determine whether lens extraction confers a significant benefit in the long term. Since those with a history of acute angle‐closure attacks may be substantially different from those with asymptomatic disease, we suggest that stratification by this variable should be adopted in studies including both types of participants. Though most forms of therapy for glaucoma are aimed at controlling intraocular pressure, adequate data on visual field changes using validated methods and validated definitions, visual acuity, vision‐related quality of life, and economic outcomes will help to evaluate different interventions for this condition comprehensively. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005555-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005555-sec-0008"></div> <div class="table" id="CD005555-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Phacoemulsification compared with laser peripheral iridotomy for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification compared with laser peripheral iridotomy for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle‐closure glaucoma </p> <p><b>Settings:</b> 30 hospital eye services in Australia (1), mainland China (1), Hong Kong (2), Malaysia (2), Singapore (2), and the UK (22) </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> laser peripheral iridotomy (LPI) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of eyes<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>laser peripheral iridotomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression of visual field loss</b> <br/>(worsening of one or more stages, according<br/>to the Glaucoma Staging System‐2) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>165 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000 (25 to 152 per 1000)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.35 (0.13 to 0.91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>216<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline to 12 months</b> <br/>(mmHg) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the control group was ‐6.48 mmHg</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the intervention group was 0.03 mmHg <b>higher</b> (95% CI ‐2.34 mmHg to 2.32 mmHg) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>257<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, the number of medications in the control group was 0.98</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, the number of medications in the intervention group was 0.70 <b>lower</b> (95% CI ‐0.89 to ‐0.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>263<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> <br/>(Degree of angle closure) </p> <p><i>(at 12 months or later)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean angle closure in the control group was 203°</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean angle closure in the intervention group was 84.93° <b>less</b> (95% CI 38.61° to 131.25°) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visual acuity</b> <br/>(ETDRS letter chart) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean visual acuity in the control group was 77.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean visual acuity in the intervention group was 2.03 letters <b>greater</b> (95% CI ‐0.77 to 4.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>242<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b><br/>(measured on the EQ‐5D; higher = better) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The average score on the EQ‐5D in the control group was 2.88</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The average score on the EQ‐5D in the intervention group was 0.04 <b>higher</b> (95% CI ‐0.16 to 0.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> <p>(one study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>EQ‐5D</b>: European Quality of Life‐5 Dimension </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision because sample size was not adequately powered (original study was powered to investigate participants with both primary angle closure (PAC) and primary angle‐closure glaucoma (PACG), whereas only participants with PACG were included in this analysis). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005555-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus viscogonioplasty for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification versus phacoemulsification plus viscogonioplasty for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle‐closure glaucoma </p> <p><b>Settings:</b> university hospital in Iran </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> phacoemulsification plus viscogonioplasty (phaco‐VGP) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification plus viscogonioplasty</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Progression of visual field loss</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline to 12 months</b> <br/>(mmHg) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the control group was ‐8.8 mmHg</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the intervention group was<br/>‐8.3 mmHg; on average, <b>0.50 mmHg higher</b> (95% CI ‐2.64 to 3.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the control group was 0.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the intervention groups was 0.1; on average, <b>0.30 fewer</b> (95% CI ‐0.55 to ‐0.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>at 6 months:</i> MD ‐0.30 (95% CI ‐0.56 to ‐0.04; 1 study, 91 eyes) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> <br/>(Spaeth grading system) </p> <p><i>(at 12 months or later)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change of angle grading in the control group was 2.0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change of angle grading in the intervention group was 1.4; on average, <b>0.60 less</b> (95% CI ‐0.91 to ‐0.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> (TISA500) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA500 in the control group was 0.054</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA500 in the intervention group was 0.020; on average, <b>0.03 less</b> (95% CI ‐0.06 to ‐0.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> (TISA750) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA750 in the control group was 0.119</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA750 in the intervention group was 0.084; on average, <b>0.03 less</b> (95% CI ‐0.06 to ‐0.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visual acuity</b> <br/>(log MAR units) </p> <p><i>(postoperatively)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the control group was 0.28</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the intervention group was 0.27; on average, <b>0.01 less</b> (95% CI ‐0.10 to 0.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> <br/><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>hyphema (3 eyes), postoperative fibrin reaction (4 eyes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>postoperative fibrin reaction (2 eyes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>IOP:</b> Intraocular pressure; <b>TISA:</b> trabecular iris space area </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for high risk of attrition bias<br/><sup>b</sup>Downgraded one level for imprecision due to wide confidence intervals </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005555-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus goniosynechialysis for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification versus phacoemulsification plus goniosynechialysis for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle closure glaucoma </p> <p><b>Settings:</b> tertiary eye care center and university hospital in Vietnam, Thailand, and Hong Kong </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> phacoemulsification plus goniosynechialysis (phaco‐GSL) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="middle"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification plus goniosynechialysis</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Progression of visual field loss</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline</b> <br/>(mmHg) </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the control group was ‐6.47 mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the intervention group was ‐6.59; on average, <b>0.12 lower</b> (95% CI ‐4.72 to 4.48) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 eyes<br/>(one study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>at 6 months</i>: MD ‐0.04 mmHg (95% CI ‐0.93 to 0.85; 1 study, 64 eyes) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the control group was 0.94</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the intervention groups was 0.56; on average, <b>0.38 fewer</b> </p> <p>(95% CI ‐1.23 to 0.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 eyes<br/>(one study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>at 6 months</i>: MD ‐0.35 (95% CI ‐0.63 to ‐0.07; 1 study, 64 eyes) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> <br/>(Anterior segment optical coherence tomography parameters) </p> <p><i>(at 6 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 eyes (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AOD500: MD ‐0.04° (95% CI ‐0.27 to 0.19)</p> <p>AOD750: MD 0.01° (95% CI ‐0.27 to 0.29)</p> <p>TISA500: MD ‐0.02° (95% CI ‐0.06 to 0.02)</p> <p>TISA750: MD ‐0.03° (95% CI ‐0.17 to 0.11)</p> <p>SSA: MD ‐1.59° (95% CI ‐6.75 to 3.57)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visual acuity</b> <br/>(log MAR units) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> <br/><i>(at 6 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>hyphema (3 eyes)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>none reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AOD:</b> angle opening distance; <b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>SSA:</b> scleral spur angle; <b>TISA:</b> trabecular iris space area </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision due to wide confidence intervals </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005555-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus trabeculectomy for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification versus phacoemulsification plus trabeculectomy for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle‐closure glaucoma </p> <p><b>Settings:</b> university hospital in Egypt </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> phacoemulsification plus trabeculectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Phacoemulsification combined with trabeculectomy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression of visual field loss</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline to 12 months</b> <br/>(mmHg) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IOP in the control group was 13.2 mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IOP in the intervention group was 12.6 mmHg; on average, <b>0.60 mmHg lower</b> </p> <p>(95% CI ‐1.99 to 0.79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the control group was 0.5</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the intervention group was 0.5; on average, there was <b>no difference</b> (95% CI ‐0.42 to 0.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean best corrected visual acuity</b> <br/>(on Snellen chart) </p> <p><i>(at final follow‐up)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the control group was 0.38</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the intervention group was 0.35: on average, <b>0.03 lower</b> (95% CI ‐0.18 to 0.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse effects</b> <br/><i>(up to 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Intraoperative and postoperative complications</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.59</b> (0.34 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580.6 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>343.8 per 1000</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Additional IOP‐lowering procedures required</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR 5.81</b> (1.41 to 23.88) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64.5 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> (e.g. the median control group risk across studies) is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for high risk of attrition bias<br/><sup>b</sup>Downgraded one level for imprecision due to wide confidence intervals </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005555-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005555-sec-0009"></div> <section id="CD005555-sec-0010"> <h3 class="title" id="CD005555-sec-0010">Description of the condition</h3> <p>Glaucoma is an umbrella term for a group of progressive optic neuropathies that are typically associated with elevated intraocular pressure (IOP), and result in characteristic patterns of visual loss and optic disc cupping. Primary angle‐closure glaucoma (PACG) is a subtype characterized by anatomical iridotrabecular contact, with consequent elevated IOP and glaucomatous optic neuropathy (<a href="./references#CD005555-bbs2-0011" title="CassonRJ . Angle closure and the lens. Clinical and Experimental Ophthalmology2011;39:3-4. ">Casson 2011</a>). </p> <section id="CD005555-sec-0011"> <h4 class="title">Epidemiology</h4> <p>Glaucoma is the third most common cause of visual impairment, and the most common irreversible cause of blindness worldwide (<a href="./references#CD005555-bbs2-0097" title="StevensG , WhiteR , FlaxmanSR , PriceH , JonasJB , KeeffeJ , et al. Global prevalence of visual impairment and blindness: magnitude and temporal trends, 1990–2010. Ophthalmology2013;120(12):2377–84.">Stevens 2013</a>). Over 60 million people are living with glaucoma, and the numbers are expected to continue rising (<a href="./references#CD005555-bbs2-0099" title="ThamYC , LiX , WongTY , QuigleyHA , AungT , ChengCY . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology2014;121(11):2081-90.">Tham 2014</a>). While primary open‐angle glaucoma is the most common subtype, PACG results in a disproportionately higher prevalence of blindness, accounting for almost half the cases of bilateral blindness due to glaucoma (<a href="./references#CD005555-bbs2-0066" title="BaskaranM , FooRC , ChengCY , NarayanaswamyAK , ZhengYF , WuR , et al. The prevalence and types of glaucoma in an urban Chinese population: the Singapore Chinese eye study. JAMA Ophthalmology2015;133(8):874-80. [PMID: 25974263]">Baskaran 2015</a>; <a href="./references#CD005555-bbs2-0069" title="DandonaL , DandonaR , MandalP , SrinivasM , JohnRK , McCartyCA , et al. Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study. Ophthalmology2000;107(9):1710-6.">Dandona 2000</a>; <a href="./references#CD005555-bbs2-0073" title="FosterPJ , JohnsonGJ . Glaucoma in China: how big is the problem?British Journal of Ophthalmology2001;85(11):1277-82.">Foster 2001</a>; <a href="./references#CD005555-bbs2-0086" title="QuigleyHA , BromanAT . The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology2006;90(3):262-7.">Quigley 2006</a>). </p> <p>The prevalence of PACG varies across the globe. It is most common in Asian populations, who comprise up to 86.5% of PACG diagnoses worldwide (<a href="./references#CD005555-bbs2-0086" title="QuigleyHA , BromanAT . The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology2006;90(3):262-7.">Quigley 2006</a>; <a href="./references#CD005555-bbs2-0099" title="ThamYC , LiX , WongTY , QuigleyHA , AungT , ChengCY . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology2014;121(11):2081-90.">Tham 2014</a>). Other risk factors include female gender, increasing age, and family history (<a href="./references#CD005555-bbs2-0062" title="AmerasingheN , AungT . Angle-closure: risk factors, diagnosis and treatment. Progress in Brain Research2008;173:31-45.">Amerasinghe 2008</a>; <a href="./references#CD005555-bbs2-0063" title="AmerasingheN , ZhangJ , ThalamuthuA , HeM , VithanaEN , ViswanathanA , et al. The heritability and sibling risk of angle closure in Asians. Ophthalmology2011;118(3):480-5.">Amerasinghe 2011</a>; <a href="./references#CD005555-bbs2-0079" title="KavithaS , ZebardastN , PalaniswamyK , WojciechowskiR , ChanES , FriedmanDS , et al. Family history is a strong risk factor for prevalent angle closure in a South Indian population. Ophthalmology2014;121(11):2091-7. [PMID: 24974379]">Kavitha 2014</a>; <a href="./references#CD005555-bbs2-0085" title="QuW , LiY , SongW , ZhouX , KangY , YanL , et al. Prevalence and risk factors for angle-closure disease in a rural Northeast China population: a population-based survey in Bin County, Harbin. Acta Ophthalmologica2011;89(6):e515-20.">Qu 2011</a>; <a href="./references#CD005555-bbs2-0086" title="QuigleyHA , BromanAT . The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology2006;90(3):262-7.">Quigley 2006</a>). Anatomical factors that increase the risk of PACG include hypermetropia, reduced axial length, increased lens thickness, and shallow anterior chamber depth (<a href="./references#CD005555-bbs2-0072" title="DevereuxJG , FosterPJ , BaasanhuJ , UranchimegD , LeePS , ErdenbeleigT , et al. Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population. Archives of Ophthalmology2000;118(2):257-63.">Devereux 2000</a>; <a href="./references#CD005555-bbs2-0080" title="LoweRF . Aetiology of the anatomical basis for primary angle-closure glaucoma. Biometrical comparisons between normal eyes and eyes with primary angle-closure glaucoma. British Journal of Ophthalmology1970;54(3):161-9.">Lowe 1970</a>; <a href="./references#CD005555-bbs2-0083" title="NongpiurME , KuJY , AungT . Angle closure glaucoma: a mechanistic review. Current Opinion in Ophthalmology2011;22(2):96-101.">Nongpiur 2011</a>; <a href="./references#CD005555-bbs2-0090" title="SalmonJF . Predisposing factors for chronic angle-closure glaucoma. Progress in Retinal and Eye Research1999;18(1):121-32. [PMID: 9920501]">Salmon 1999</a>; <a href="./references#CD005555-bbs2-0095" title="SngCC , FooLL , ChengCY , Allen JC Jr, HeM , KrishnaswamyG , et al. Determinants of anterior chamber depth: the Singapore Chinese Eye Study. Ophthalmology2012;119(6):1143-50.">Sng 2012</a>). Several potentially responsible candidate genes have been identified, but the relationship is complex, and the mechanisms are as yet unclear (<a href="./references#CD005555-bbs2-0092" title="ShastryBS . Genetic susceptibility to primary angle closure glaucoma (PACG). Discovery Medicine2013;15(80):17-22.">Shastry 2013</a>). </p> </section> <section id="CD005555-sec-0012"> <h4 class="title">Clinical Presentation and Diagnosis</h4> <p>Chronic PACG presents insidiously – over time, patients may develop visual field defects characteristic of glaucoma if the longstanding pressure damage to the optic nerve is not corrected, which means that it is often asymptomatic until the late stages. Signs include optic disc cupping, elevated IOP, and a narrow or closed iridocorneal angle on gonioscopy. Ultrasound biomicroscopy and anterior segment optical coherence tomography may also be used to assess angle<br/>configuration. </p> </section> </section> <section id="CD005555-sec-0013"> <h3 class="title" id="CD005555-sec-0013">Description of the intervention</h3> <p>PACG treatment aims to lower IOP and thereby arrest optic nerve damage. This can be achieved by a stepped approach, using medical treatment (ocular hypotensive agents), laser (laser peripheral iridotomy, argon laser peripheral iridoplasty, selective laser trabeculoplasty), surgical means (lens extraction, trabeculectomy, goniosynechialysis), or any combination of these treatments. </p> <p>Lens extraction is increasingly viewed as a viable treatment for PACG. This is typically achieved with phacoemulsification and intraocular lens (IOL) implantation, although older techniques such as extracapsular cataract extraction may uncommonly be used complex cases where phacoemulsification proves difficult, and a variation thereof (manual small incision cataract surgery) is commonly used in developing countries. </p> </section> <section id="CD005555-sec-0014"> <h3 class="title" id="CD005555-sec-0014">How the intervention might work</h3> <p>Relative pupillary block and angle crowding are the two main mechanisms underlying the pathogenesis of PACG (<a href="./references#CD005555-bbs2-0102" title="WrightC , TawfikMA , WaisbourdM , KatzLJ . Primary angle-closure glaucoma: an update. Acta Ophthalmologica2016;94(3):217-25.">Wright 2015</a>). </p> <p>In relative pupillary block, there is obstruction of the free flow of aqueous humor from the posterior to the anterior chamber of the eye. The increased pressure gradient across the pupil forces the iris to bow forwards, narrowing the iridocorneal angle, and reducing access to the trabecular meshwork through the apposition of lens and iris at the pupil. Prolonged iridotrabecular contact can also lead to the formation of peripheral anterior synechiae (PAS), which can exacerbate the pupillary block. </p> <p>Another mechanism is angle crowding, which often coexists with pupillary block, but may also cause PACG by itself. Angle crowding may be due to plateau iris, an anatomical configuration wherein the peripheral iris root is compressed against the trabecular meshwork by more anteriorly positioned ciliary processes, thus predisposing to iridocorneal contact (<a href="./references#CD005555-bbs2-0089" title="RitchR , ChangBM , LiebmannJM . Angle closure in younger patients. Ophthalmology2003;110(10):1880-9.">Ritch 2003</a>; <a href="./references#CD005555-bbs2-0093" title="ShuklaS , DamjiKF , HarasymowyczP , ChialantD , KentJS , ChevrierR , et al. Clinical features distinguishing angle closure from pseudoplateau versus plateau iris. British Journal of Ophthalmology2008;92(3):340-4.">Shukla 2008</a>; <a href="./references#CD005555-bbs2-0100" title="WandM , GrantWM , SimmonsRJ , HutchinsonBT . Plateau iris syndrome. Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology1977;83(1):122-30.">Wand 1977</a>). It may also result from other abnormal iris configurations, such as a thick peripheral iris roll (<a href="./references#CD005555-bbs2-0091" title="ShabanaN , AquinoMCD , SeeJ , ZhengC , TanAM , NolanWP , et al. Quantitative evaluation of anterior chamber parameters using anterior segment optical coherence tomography in primary angle closure mechanisms. Clinical and Experimental Ophthalmology2012;40(8):792-801.">Shabana 2012</a>). </p> <p>More recent studies have established that exaggerated lens vault plays an important role in the pathogenesis of PACG. Compared to normal eyes, eyes with PACG were found to have thickened crystalline lens with a greater lens vault that displaces the iris anteriorly, thereby reducing the anterior chamber depth (<a href="./references#CD005555-bbs2-0084" title="OzakiM , NongpiurME , AungT , HeM , MizoguchiT . Increased lens vault as a risk factor for angle closure: confirmation in a Japanese population. Graefe's Archive for Clinical and Experimental Ophthalmology2012;250(12):1863-8.">Ozaki 2012</a>; <a href="./references#CD005555-bbs2-0083" title="NongpiurME , KuJY , AungT . Angle closure glaucoma: a mechanistic review. Current Opinion in Ophthalmology2011;22(2):96-101.">Nongpiur 2011</a>; <a href="./references#CD005555-bbs2-0091" title="ShabanaN , AquinoMCD , SeeJ , ZhengC , TanAM , NolanWP , et al. Quantitative evaluation of anterior chamber parameters using anterior segment optical coherence tomography in primary angle closure mechanisms. Clinical and Experimental Ophthalmology2012;40(8):792-801.">Shabana 2012</a>). As such, lens extraction can plausibly relieve pupillary block and angle crowding, thus aiding in IOP control. Indeed, there is evidence that replacing the thickened cataractous lens with a synthetic IOL can deepen the anterior chamber depth by 1.0 mm or more (<a href="./references#CD005555-bbs2-0020" title="HayashiK , HayashiH , NakaoF , HayashiF . Changes in anterior chamber angle width and depth after intraocular lens implantation in eyes with glaucoma. Ophthalmology2000;107(4):698-703. ">Hayashi 2000</a>; <a href="./references#CD005555-bbs2-0048" title="YangCH , HungPT . Intraocular lens position and anterior chamber angle changes after cataract extraction in eyes with primary angle-closure glaucoma. Journal of Cataract and Refractive Surgery1997;23(7):1109-13. ">Yang 1997</a>), and early non‐randomized trials showed significant improvement in IOP in PACG patients following cataract extraction (<a href="./references#CD005555-bbs2-0021" title="HayashiK , HayashiH , NakaoF , HayashiF . Effect of cataract surgery on intraocular pressure control in glaucoma patients. Journal of Cataract and Refractive Surgery2001;27(11):1779-86. ">Hayashi 2001</a>; <a href="./references#CD005555-bbs2-0029" title="KubotaT , ToguriI , OnizukaN , MatsuuraT . Phacoemulsification and intraocular lens implantation for angle closure glaucoma after relief of pupillary block. Ophthalmologica2003;217(5):325-8. ">Kubota 2003</a>). </p> </section> <section id="CD005555-sec-0015"> <h3 class="title" id="CD005555-sec-0015">Why it is important to do this review</h3> <p>There is some evidence that lens extraction may help slow the progression of PACG. However, its effectiveness compared to other conventional interventions has not been systematically evaluated. In addition, there is no consensus as to whether lens extraction is sufficiently effective that it should be performed on PACG patients without coexisting cataract (i.e., clear lens extraction), which is important because the surgery is not risk‐free. </p> <p>The original version of this review did not find any randomized controlled trials on the topic, and the two eligible non‐randomized studies did not provide proof of the effectiveness of lens extraction over other interventions for chronic PACG (<a href="./references#CD005555-bbs2-0104" title="FriedmanDS , VedulaSS . Lens extraction for chronic angle-closure glaucoma. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD005555. [DOI: 10.1002/14651858.CD005555.pub2]">Friedman 2006</a>). There has been increasing interest in this subject since then. With the rising disease burden, it is timely for a systematic examination of the evidence on the utility of lens extraction in the treatment of<br/>chronic PACG. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005555-sec-0016" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005555-sec-0016"></div> <p>To assess the effectiveness of lens extraction compared to other interventions in the treatment of chronic primary angle‐closure glaucoma in people without previous acute angle‐closure attacks. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005555-sec-0017" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005555-sec-0017"></div> <section id="CD005555-sec-0018"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005555-sec-0019"> <h4 class="title">Types of studies</h4> <p>We included only randomized controlled trials (RCT) in the updated review. We excluded the non‐randomized comparative studies from the original version of this review. We did not place any restrictions relating to language, date of publication, or number of participants. </p> </section> <section id="CD005555-sec-0020"> <h4 class="title">Types of participants</h4> <p>We included studies that enrolled participants diagnosed with chronic primary angle‐closure glaucoma (PACG), defined as gonioscopic evidence of angle closure in association with either glaucomatous optic neuropathy with or without visual field defects, or elevated intraocular pressure (IOP). </p> <p>We excluded participants with a known history of acute angle‐closure attacks. This population may develop chronic PACG, but the disease may differ substantially from those with asymptomatic disease (<a href="./references#CD005555-bbs2-0064" title="AngLP , AungT , ChuaWH , YipLW , ChewPT . Visual field loss from primary angle-closure glaucoma: a comparative study of symptomatic and asymptomatic disease. Ophthalmology2004;111(9):1636-40.">Ang 2004</a>; <a href="./references#CD005555-bbs2-0067" title="ChenYJ , TaiMC , ChengJH , ChenJT , ChenYH , LuDW . The longitudinal changes of the visual field in an Asian population with primary angle-closure glaucoma with and without an acute attack.. Journal of Ocular Pharmacology and Therapeutics2012;28(2):529-35.">Chen 2012</a>; <a href="./references#CD005555-bbs2-0098" title="ThamCC , LaiJS , KwongYY , LamSW , ChanJC , ChiuTY , et al. Correlation of previous acute angle-closure attack with extent of synechial angle closure in chronic primary angle-closure glaucoma patients. Eye2009;23(4):920-3.">Tham 2009a</a>). Where studies included both participants with chronic PACG with known symptomatic attacks in the past and those without, we attempted to procure data on the latter group alone. We placed no restrictions on age, gender, ethnicity, comorbidities, use of adjunctive medications, or number of participants. </p> </section> <section id="CD005555-sec-0021"> <h4 class="title">Types of interventions</h4> <p>We included studies that compared lens extraction with other treatment modalities for chronic PACG, including but not limited to laser iridotomy, medications, and laser iridoplasty. </p> </section> <section id="CD005555-sec-0022"> <h4 class="title">Types of outcome measures</h4> <section id="CD005555-sec-0023"> <h5 class="title">Primary outcomes</h5> <p>(1) Proportion of participants with evidence of progression of visual field loss at different follow‐up time points. The main primary outcome was at one year of follow‐up. We adopted the criteria in the included studies to define progression of visual field loss as measured using a validated method. </p> <p>(2) Mean change in IOP from baseline to one year, measured by any method. We also planned to report the mean change in IOP from baseline to different follow‐up time points. If data on mean change from baseline and its standard deviation were not reported in the manuscript and could not be obtained from the authors, we planned to analyze the final mean IOPs at different follow‐up time points. </p> </section> <section id="CD005555-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p>(1) Mean change in depth of the anterior chamber from baseline in millimeters, measured by any method </p> <p>(2) Number of medications used to control IOP at six months, one year, and at different follow‐up time points, as reported in the included studies </p> <p>(3) Gonioscopic findings <b>–</b> we planned to summarize the available information on the examination of the angle, including angle width, from the included studies. </p> <p>(4) Visual acuity as reported in the included studies.</p> <section id="CD005555-sec-0025"> <h6 class="title">Adverse effects</h6> <p>We summarized adverse effects related to lens extraction reported in the included studies. </p> </section> <section id="CD005555-sec-0026"> <h6 class="title">Quality of life measures</h6> <p>We planned to summarize quality of life outcomes reported in the included studies.</p> </section> <section id="CD005555-sec-0027"> <h6 class="title">Follow<i>‐</i>up </h6> <p>There were no restrictions based on length of follow‐up.</p> </section> </section> </section> </section> <section id="CD005555-sec-0028"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD005555-sec-0029"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Eyes and Vision Information specialist conducted systematic searches in the following databases for RCTs and controlled clinical trials. We placed no restrictions on language or year of publication. The date of the search was 13 December 2019. </p> <p> <ul id="CD005555-list-0001"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 12 [which contains the Cochrane Eyes and Vision Trials Register]) in the Cochrane Library (searched 13 December 2019; <a href="./appendices#CD005555-sec-0118">Appendix 1</a>); </p> </li> <li> <p>MEDLINE Ovid (1946 to 13 December 2019; <a href="./appendices#CD005555-sec-0119">Appendix 2</a>); </p> </li> <li> <p>Embase Ovid (1980 to 13 December 2019; <a href="./appendices#CD005555-sec-0120">Appendix 3</a>); </p> </li> <li> <p>LILACS (Latin American and Caribbean Health Sciences Literature Database; 1982 to 13 December 2019; <a href="./appendices#CD005555-sec-0121">Appendix 4</a>); </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>; searched 13 December 2019; <a href="./appendices#CD005555-sec-0122">Appendix 5</a>); </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP; <a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>; searched 13 December 2019; <a href="./appendices#CD005555-sec-0123">Appendix 6</a>). </p> </li> </ul> </p> </section> <section id="CD005555-sec-0030"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of the included studies. We planned to contact the primary investigators of identified RCTs for details of any additional trials not found by our electronic and manual searches. We used the Science Citation Index to search for references that cited the included studies. </p> </section> </section> <section id="CD005555-sec-0031"> <h3 class="title" id="CD005555-sec-0031">Data collection and analysis</h3> <section id="CD005555-sec-0032"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed the titles and abstracts of all reports identified by the electronic and manual searches. We labeled each report as (a) definitely exclude, (b) unsure, or (c) definitely include. We excluded studies labeled as 'definitely exclude'. We assessed studies labeled as 'definitely include' for risk of bias. We assessed the full text of abstracts labelled as 'unsure' according to the inclusion criteria for this review. We recorded the studies excluded after the full‐text review as well as the reasons for exclusion. We resolved any discrepancies between our assessments through discussion. </p> </section> <section id="CD005555-sec-0033"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently recorded primary and secondary outcome data in Covidence (<a href="./references#CD005555-bbs2-0068" title="Covidence. Version accessed 13 December 2020. Melbourne, Australia: Veritas Health Innovation. Available at covidence.org.">Covidence</a>). We resolved discrepancies through discussion. One review author entered the data into Review Manager 5; a second review author verified the accuracy (<a href="./references#CD005555-bbs2-0088" title="Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). We contacted study authors to clarify any points of doubt. </p> </section> <section id="CD005555-sec-0034"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For each included trial, two review authors independently assessed the methodological quality and risk of bias according to the guidelines in Chapter 8 of the <i>Cochrane Handbook for Systematic Review of Interventions</i> (<a href="./references#CD005555-bbs2-0077" title="HigginsJPT , AltmanDG , SterneJAC , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We assessed the following domains: </p> <p>1. Sequence generation (selection bias): randomization methods such as computer‐generated random numbers were considered to be at low risk of bias; methods such as alternation were considered to be at high risk of bias; methods using medical record numbers, social security numbers, etc. were considered quasi‐randomized, and were consequently deemed to be at high risk of bias as well. </p> <p>2. Allocation concealment (selection bias): methods such as central randomization and the use of sequentially numbered sealed envelopes were considered to be at low risk of bias. If participants or investigators were able to foresee upcoming assignments (e.g. using open random allocation schedule, date of birth, alternation etc.), the study was judged as having high risk of bias. </p> <p>3. Masking (performance bias and detection bias): we assessed masking of outcome assessors where masking was feasible. Masking of participants and physicians was not feasible due to the nature of the intervention studied. If outcome assessors were adequately masked to the assignments, we judged the study as having low risk of bias. If masking was incomplete and outcome measurements were likely to be influenced by lack of masking, the study was judged as having high risk of bias for this domain. </p> <p>4. Incomplete outcome data (attrition bias): we assessed methods for handling loss to follow‐up and missing data. We judged the study as having low risk of bias if there were no missing outcome data, or where intention‐to‐treat analysis was followed. We judged the study as having high risk of bias if intention‐to‐treat analysis was not followed, or reasons for missing outcome data were likely to be related to true outcome. We attempted to contact trial authors for missing data. Where analyses involved imputing data on participants who dropped out or were lost to follow‐up, we extracted information on methods used for such imputation. </p> <p>5. Selective outcome reporting (reporting bias): we attempted to assess for evidence of selective reporting of outcomes or analyses on selective populations by comparing the published results to the original protocol. We judged the study as having low risk of reporting bias if the study protocol was published and all pre‐specified outcomes were adequately reported. If not all pre‐specified outcomes or outcomes prescribed in Methods section were reported or outcomes were reported incompletely, we judged the study as having high risk of bias for this domain. </p> <p>6. Other sources of bias: we evaluated evidence of other sources of bias. We judged high risk of bias for this domain if the study had a potential source of bias due to the specific study design, and judged as low risk of bias if none of such bias was identified. We judged as having unclear risk of bias if there was insufficient information to allow judgement. </p> </section> <section id="CD005555-sec-0035"> <h4 class="title">Measures of treatment effect</h4> <p>We calculated summary risk ratios (RR) with 95% confidence intervals (CIs) for dichotomous outcomes. In this review, dichotomous outcomes included the primary outcome ‘proportion of patients with evidence of progression of visual field loss.’ For one trial, we presented odds ratio (OR) ‐ one author (SSV) analyzed the individual participant data acquired from the original trial, following its prespecified statistical analysis plan to account for correlation within participants (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>). This analysis was performed using Stata (<a href="./references#CD005555-bbs2-0096" title="Stata. Version 15. College Station, TX, USA: StataCorp, 2017. Available at www.stata.com.">Stata</a>). </p> <p>We calculated the mean difference (MD) with 95% CIs for normally distributed continuous outcomes. We did not use the standardized mean difference (SMD) because all included studies reported outcomes on the same scale. In this review, continuous outcomes included the primary outcome ‘mean change in IOP’, and the secondary outcomes ‘mean change in anterior chamber depth’, ‘mean change in number of medications used to control IOP’, ‘gonioscopic findings’, and ‘mean change in visual acuity’. </p> </section> <section id="CD005555-sec-0036"> <h4 class="title">Unit of analysis issues</h4> <p>In one study, the participant was used as the unit of randomization, while the eye was used as the unit of analysis. However, the analysis did not take into account correlation between eyes of the same participant (<a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). Another study used the eye as a unit of analysis, without explicitly stating whether one or both eyes of a participant were included (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>). </p> </section> <section id="CD005555-sec-0037"> <h4 class="title">Dealing with missing data</h4> <p>We contacted trial investigators to obtain additional information, individual participant data, or both. We used the published data available when we did not receive a response. </p> </section> <section id="CD005555-sec-0038"> <h4 class="title">Assessment of heterogeneity</h4> <p>We quantified the proportion of intra‐study variability that could be explained by heterogeneity using the I² statistic (<a href="./references#CD005555-bbs2-0076" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta-analysis. Statistics in Medicine2002;21(11):1539-58.">Higgins 2002</a>). We examined the inter‐study variance using Tau². When we observed substantial statistical heterogeneity (defined here as I² &gt; 50%) in a particular outcome, we did not combine the study results in a meta‐analysis, but reported them in a qualitative (narrative) summary instead. </p> </section> <section id="CD005555-sec-0039"> <h4 class="title">Assessment of reporting biases</h4> <p>For selective outcome reporting, we compared the prespecified outcomes in protocols or trial registries with outcomes reported in published papers. For the studies for which the protocol was not publicly available, we compared the outcomes presented in the Methods section with those reported in the Results section of the published papers. We did not assess for publication bias as we did not include 10 or more studies in meta‐analysis. </p> </section> <section id="CD005555-sec-0040"> <h4 class="title">Data synthesis</h4> <p>Data analysis followed the guidelines set out in Chapter 9 of the <i>Cochrane Handbook for Systematic Review of Interventions</i> (<a href="./references#CD005555-bbs2-0070" title="DeeksJJ , HigginsJPT , AltmanDG , editor(s). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Deeks 2011</a>). </p> <p>We planned to conduct a meta‐analysis if there was no substantial heterogeneity. We planned to use the fixed‐effects model for outcomes with fewer than three studies, and the random‐effects model for those containing three or more studies. </p> </section> <section id="CD005555-sec-0041"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Where heterogeneity was high (I² &gt; 50%), we planned subgroup analyses to explore the underlying causes. This was conditional on having sufficient data to carry this out. </p> </section> <section id="CD005555-sec-0042"> <h4 class="title">Sensitivity analysis</h4> <p>Where appropriate, we planned sensitivity analyses to determine the impact of excluding randomized studies of higher risk of bias, quasi‐randomized studies, unpublished studies, or industry‐funded studies from the meta‐analysis. This was ultimately unnecessary because of the limited number of eligible studies. </p> </section> <section id="CD005555-sec-0043"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created 'Summary of findings' tables for the main comparisons. Two review authors independently graded the quality of the body of evidence for each outcome as one of four levels (i.e. high, moderate, low, or very low) using the GRADE approach (<a href="./references#CD005555-bbs2-0075" title="GRADEpro GDT. Version accessed 20 September 2019. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). We resolved disagreement by discussion and obtaining consensus within the review team. We downgraded the certainty of the body of evidence by assessing the following parameters: </p> <p> <ol id="CD005555-list-0002"> <li> <p>High risk of bias among included studies;</p> </li> <li> <p>Indirectness of evidence;</p> </li> <li> <p>Unexplained heterogeneity or inconsistency of results;</p> </li> <li> <p>Imprecision of results (i.e. wide confidence intervals);</p> </li> <li> <p>High probability of publication bias.</p> </li> </ol> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005555-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005555-sec-0044"></div> <section id="CD005555-sec-0045"> <h3 class="title">Description of studies</h3> <section id="CD005555-sec-0046"> <h4 class="title">Results of the search</h4> <p>The electronic searches for the original review were conducted in July 2005 and April 2006; the details were described previously (<a href="./references#CD005555-bbs2-0104" title="FriedmanDS , VedulaSS . Lens extraction for chronic angle-closure glaucoma. Cochrane Database of Systematic Reviews2006, Issue 3. Art. No: CD005555. [DOI: 10.1002/14651858.CD005555.pub2]">Friedman 2006</a>). In brief, no relevant randomized controlled trials (RCT) were identified from 395 records at the time. An updated search on 13 December 2019 yielded 2381 records. Five additional records were identified after searching through reference lists. After screening titles and abstracts, we retrieved 52 full‐text reports for further evaluation. After screening the full texts, we included eight relevant studies (17 records); identified one ongoing study (one record), six studies (six records) await classification, and we excluded 28 studies (28 records). In total, we have excluded 45 studies listed in the '<a href="./references#CD005555-sec-0134" title="">Characteristics of excluded studies</a>' table. We listed six studies in the '<a href="./references#CD005555-sec-0135" title="">Characteristics of studies awaiting classification</a>' section; we were unable to retrieve two articles, or clarify the eligibility of participants for the remaining four studies (one of which was identified from a manual search). We listed the protocol of an ongoing RCT which commenced in April 2019 under <a href="./references#CD005555-sec-0136" title="">Characteristics of ongoing studies</a> (<a href="./references#CD005555-bbs2-0060" title="ChiCTR1900022198. A multicenter randomized controlled study for lens extraction combined with intraocular lens implantation for primary angle-closure glaucoma. apps.who.int/trialsearch/Trial2.aspx?TrialID=ChiCTR1900022198 (first received 30 March 2019). ">ChiCTR1900022198</a>). We attempted to contact the relevant authors. We will update the review with relevant information if and when they become available. The flow diagram of the search results is shown in <a href="#CD005555-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD005555-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD005555-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD005555-sec-0047"> <h4 class="title">Included studies</h4> <section id="CD005555-sec-0048"> <h5 class="title">Types of studies</h5> <p>The previous version of this review comprised only non‐randomized comparative studies as no eligible RCTs were identified at the time. For this update, we focused solely on RCTs. </p> <p>We included a total of eight RCTs in this update. Three studies were initially eligible for inclusion in the review (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>, <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>, <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). Another included participants with both primary angle‐closure glaucoma (PACG) and primary angle closure (PAC), but subsequently provided data for participants with PACG, such that we could perform individual patient data analysis for inclusion in the review (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>). Four studies did not meet the eligibility criteria initially, but we obtained data on participants with PACG without a previous history of symptomatic acute angle closure attacks (as per our eligibility criteria) from the trial authors, which we have included below (<a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>; <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). </p> </section> <section id="CD005555-sec-0049"> <h5 class="title">Types of participants</h5> <p>The eight eligible RCTs included comprised 914 eyes in total. Of these, 513 eyes met our inclusion criteria of having PACG without a previous history of acute angle closure attacks. This number does not include three studies, for which the number of eligible eyes was unclear (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). </p> <p><a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> was a multicenter trial that recruited from across the United Kingdom, Australia, and Southeast Asia (China, Hong Kong, Malaysia, and Singapore). <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a> recruited participants from Southeast Asia (Hong Kong, Singapore, Thailand, Vietnam), as did <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>, <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>, and <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>, all of which recruited from Hong Kong and China. <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> took place in India, <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a> in Iran, and <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> in Egypt. </p> <p>PACG was defined as occludable angles (at least 180 degrees of iridotrabecular contact in all studies, apart from <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>, which specified at least 270 degrees); glaucomatous visual field loss or glaucomatous optic neuropathy, or both; and elevated IOP. <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> enrolled participants who were newly diagnosed with PACG, as well as those with PAC with an intraocular pressure (IOP) of 30 mmHg or higher. Notably, study participants did not have symptomatic cataracts. This was also the case for <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>, which only evaluated participants with medically uncontrolled PACG without cataracts. Conversely, all participants in <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>, <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>, <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a> had PACG as well as visually significant cataracts in the study eye. The final study comprised a mix of eyes with PACG with and without cataracts (<a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>). </p> <p>Four studies included participants with a previous history of acute angle closure attacks (<a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>; <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). We obtained data for those with PACG without such a history through private correspondence with the authors of these studies. </p> <p>All eight studies had two study arms, and all the baseline characteristics were equivalent in both arms, apart from <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>, which reported a discrepancy in the mean central corneal thickness across study arms. </p> </section> <section id="CD005555-sec-0050"> <h5 class="title">Types of interventions</h5> <p><a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> compared phacoemulsification (clear lens extraction) and standard care (laser peripheral iridotomy). For the phacoemulsification group, synechialysis was allowed according to local practice. For the standard care group, laser iridoplasty was subsequently allowed if angle closure persisted, and participants could undergo lens extraction only if they subsequently developed a visually significant cataract or if their ophthalmologist recommended this to help with IOP control. </p> <p><a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a> compared phacoemulsification and phacoemulsification combined with viscogonioplasty (phaco‐VGP), a technique for breaking the PAS using a cohesive viscoelastic. This was injected near the iridocorneal angle twice for 360°, without touching the angle with the cannula, i.e. no surgical instruments were used to mechanically break the PAS, in contrast to phaco‐GSL. </p> <p>Both <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> and <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a> compared phacoemulsification and phacoemulsification combined with goniosynechialysis (phaco‐GSL). The surgeons in <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> used a viscoelastic cannula to mechanically break the PAS along approximately 270 degrees of the iridocorneal angle. In <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>, GSL was performed using an iris repositor or similar. </p> <p>Three studies compared phacoemulsification versus combined phaco‐trabeculectomy (<a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>; <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>). </p> <p>One compared phacoemulsification versus trabeculectomy with adjunctive mitomycin C (MMC) (<a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). </p> </section> <section id="CD005555-sec-0051"> <h5 class="title">Types of outcomes</h5> <section id="CD005555-sec-0052"> <h6 class="title">Primary outcomes</h6> <p>Two studies evaluated the proportion of participants with evidence of progression of visual field loss at 24 months (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>). None of the eight studies assessed this parameter at 12 months postoperatively, although <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> reported progression in visual field loss at 12, 24, and 36 months. </p> <p>Two studies reported the mean change in IOP from baseline to 12 months (<a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). The remaining six reported the final mean IOP at various time points: <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> up to six months; <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> up to 12 months; three up to 24 months, including at 12 months (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>); <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> up to 36 months (including at 12 months). We also obtained the raw data from the authors of <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> to calculate the mean change in IOP from baseline to 12 months. </p> </section> <section id="CD005555-sec-0053"> <h6 class="title">Secondary outcomes</h6> <p>None of the eight studies reported the mean change in anterior chamber depth (ACD) from baseline. </p> <p>All eight studies evaluated the mean number of IOP‐lowering medications required at various follow‐up intervals: <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> at six months; <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> at 6,12, 24, and 36 months; <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> and <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a> at 1, 3, 6, and 12 months; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a> at 12 months; and <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>, <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>, and <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a> at 3‐monthly intervals up to 24 months. </p> <p>Two studies reported the mean change in gonioscopic grading from baseline: one at 12 months postoperatively (<a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>), and the other at the last follow‐up visit, which appears to have varied for each participant (<a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> reported the degree of appositional and synechial angle closure at 36 months postoperatively. Two studies also measured changes in the iridocorneal angle in terms of quantitative anterior segment optical coherence tomography (AS‐OCT) parameters (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). </p> <p>Five studies described the best corrected visual acuity (BCVA) at various time points: <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> at 12 and 36 months; <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> at the final follow‐up (varying intervals after 12 months for each individual); and <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>, <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>, and <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a> at 12 and 24 months postoperatively. </p> </section> <section id="CD005555-sec-0054"> <h6 class="title">Adverse effects</h6> <p>Seven studies reported both intraoperative and postoperative complications in both treatment arms (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>; <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>; <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). One described only postoperative complications, and it was unclear whether intraoperative complications were documented (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>). </p> </section> <section id="CD005555-sec-0055"> <h6 class="title">Quality of life measures</h6> <p>Only one study included self‐reported quality of life as an outcome. <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> measured health status using the European Quality of Life‐5 Dimensions (EQ‐5D), as well as vision‐related quality of life, using the National Eye Institute Visual Function Questionnaire‐25 and the Glaucoma Utility Index. </p> </section> </section> </section> <section id="CD005555-sec-0056"> <h4 class="title">Excluded studies</h4> <p>The 45 studies excluded after full text review are briefly described in the '<a href="./references#CD005555-sec-0134" title="">Characteristics of excluded studies</a>' section. In summary, we excluded 29 studies due to incorrect study design (not RCTs), ten studies due to ineligible participants (not participants with chronic PACG), and six studies due to interventions. </p> </section> </section> <section id="CD005555-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>We summarized the risk of bias assessments in <a href="#CD005555-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD005555-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD005555-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> <section id="CD005555-sec-0058"> <h4 class="title">Allocation</h4> <p>All eight studies reported adequate methods of generating the randomization schedule. Five studies used random number tables (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>; <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>) ; one used computer‐generated random blocks (<a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>); one randomized participants in a 1:1 ratio by way of a random‐number generator (<a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>); while one created a randomization schedule with the aid of a web‐based application that used sex, center, ethnic origin, diagnosis, and one or both eyes suitable for treatment as minimization covariates (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>). </p> <p>Two studies used appropriate allocation concealment methods (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). It was unclear from the text whether allocation concealment took place in the remaining six studies. </p> </section> <section id="CD005555-sec-0059"> <h4 class="title">Blinding</h4> <p>Three studies were at low risk of detection bias as they blinded both participants and outcome assessors to the intervention performed (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). </p> <p>For the remaining five studies, the inherent differences in the interventions compared meant that it was difficult to mask participants and study personnel, particularly the surgeons performing the intervention. <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> took steps to counteract this, undertaking a rigorous standardized masking protocol to minimize detection bias for IOP assessment. One study reported that the study personnel were not masked (<a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>), while this was not mentioned in three studies (<a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>; <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). </p> </section> <section id="CD005555-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>We judged three studies to be at low risk of bias because intention‐to‐treat analyses were performed as planned in their study protocol (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). This was presumed to be the case for a further two that had no apparent losses to follow‐up (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>). </p> <p>We judged three studies to be at high risk of attrition bias (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>). Only data from participants who completed follow‐up were analyzed and presented; missing participants were excluded from the outcomes and baseline data completely, and their reasons for dropping out were not elucidated. </p> </section> <section id="CD005555-sec-0061"> <h4 class="title">Selective reporting</h4> <p>We deemed three studies to be at low risk of reporting bias as the results of all outcomes described in their protocols were duly reported (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>). </p> <p>One study was at risk of reporting bias ‐ the results of several prespecified outcome measures described in the protocol were not reported (<a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). </p> <p>The risk was unclear for four studies because we had no protocol to compare the results against (<a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>; <a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a>; <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>). </p> </section> <section id="CD005555-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>One study was at unclear risk because it is still ongoing and only the interim report was available (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>). We judged the remaining studies to be at low risk of bias. </p> </section> </section> <section id="CD005555-sec-0063"> <h3 class="title" id="CD005555-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD005555-tbl-0001"><b>Summary of findings 1</b> Phacoemulsification compared with laser peripheral iridotomy for primary angle‐closure glaucoma</a>; <a href="./full#CD005555-tbl-0002"><b>Summary of findings 2</b> Phacoemulsification versus phacoemulsification plus viscogonioplasty for primary angle‐closure glaucoma</a>; <a href="./full#CD005555-tbl-0003"><b>Summary of findings 3</b> Phacoemulsification versus phacoemulsification plus goniosynechialysis for primary angle‐closure glaucoma</a>; <a href="./full#CD005555-tbl-0004"><b>Summary of findings 4</b> Phacoemulsification versus phacoemulsification plus trabeculectomy for primary angle‐closure glaucoma</a> </p> <p>Meta‐analysis was not possible due to the absence of equivalent intervention groups, relevant data, and follow‐up periods. We therefore presented the results narratively. We show the summary of results for each comparison in <a href="#CD005555-tbl-0005">Table 1</a>. </p> <div class="table" id="CD005555-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary table</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Intervention</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laser peripheral iridotomy (LPI)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification plus viscogonioplasty</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification plus goniosynechialysis (phaco‐GSL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification plus trabeculectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trabeculectomy</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> </p> <p>(Data not presented for <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Progression of visual field loss </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.49 (95% CI 0.24 to 0.92) at 6 months;</p> <p>OR 0.35 (95% CI 0.13 to 0.91) at 12 months;</p> <p>OR 0.37 (95% CI 0.17 to 0.82) at 24 months;</p> <p>OR 0.42 (95% CI 0.20 to 0.87) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean change in IOP</b> </p> <p><b>(in mmHg)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.65 mmHg (95% CI ‐3.12 to 1.82) at 6 months;</p> <p>MD ‐0.03 mmHg (95% CI ‐2.34 to 2.32) at 12 months;</p> <p>MD 0.74 mmHg (95% CI ‐1.66 to 3.13) at 24 months;</p> <p>MD 1.04 mmHg (95% CI ‐1.22 to 3.31) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.50 mmHg (95% CI ‐2.64 to 3.64; 91 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.04 mmHg (95% CI ‐0.93 to 0.85; 1 study, 64 eyes) at 6 months;</p> <p>MD ‐0.12 mmHg (95% CI ‐4.72 to 4.48; 1 study, 32 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.50 mmHg (95% CI ‐1.95 to 2.95) at 1 month;</p> <p>MD 0.00 mmHg (95% CI ‐2.36 to 2.36) at 3 months;</p> <p>MD ‐0.30 mmHg (95% CI ‐1.89 to 1.29) at 6 months;</p> <p>MD ‐0.60 mmHg (95% CI ‐1.99 to 0.79) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean change in anterior chamber depth</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of medications used to control IOP</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.65 (95% CI ‐0.85 to ‐0.45) at 6 months;</p> <p>MD ‐0.70 (95% CI ‐0.89 to ‐0.51) at 12 months;</p> <p>MD ‐0.73 (95% CI ‐0.94 to ‐0.52) at 24 months;</p> <p>MD ‐0.65 (95% CI ‐0.87 to ‐0.43) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.30 (95% CI ‐0.56 to ‐0.04; 91 eyes) at 6 months;</p> <p>MD ‐0.30 (95% CI ‐0.55 to ‐0.05; 91 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.35 (95% CI ‐0.63 to ‐0.07; 1 study, 64 eyes) at 6 months;</p> <p>MD ‐0.38 (95% CI ‐1.23 to 0.47; 1 study, 32 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 (95% CI 0.01 to 0.59) at 1 month;</p> <p>MD 0.40 (95% CI 0.06 to 0.74) at 3 months;</p> <p>MD 0.20 (95% CI ‐0.15 to 0.55) at 6 months;</p> <p>MD 0.00 (95% CI ‐0.42 to 0.42) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gonioscopic findings</b> </p> <p><b>(measured in degrees)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Appositional angle closure</i><br/>MD ‐84.93° (95% CI ‐131.25 to ‐38.61) at 12 months; </p> <p>MD ‐74.16° (95% CI ‐121.34 to ‐26.98) at 36 months</p> <p><i>Synechial angle closure</i> </p> <p>MD ‐69.63° (95% CI, ‐104.34 to ‐16.92) at 12 months;</p> <p>MD 1.12 (95% CI, ‐42.37 to 44.62) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Angle width</i><br/>MD ‐0.60 (95% CI ‐0.91 to ‐0.29; 91 eyes) at 12 months or later; </p> <p><i>TISA500</i><br/>MD ‐0.03 (95% CI ‐0.06 to ‐0.01; 91 eyes) at 12 months; </p> <p><i>TISA750</i><br/>MD ‐0.03 (95% CI ‐0.06 to ‐0.01; 91 eyes) at 12 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>AOD500</i><br/>MD ‐0.04 (95% CI ‐0.27 to 0.19; 1 study, 64 eyes); at 6 months; </p> <p><i>AOD750</i><br/>MD 0.01 (95% CI ‐0.27 to 0.29; 1 study, 64 eyes) at 6 months; </p> <p><i>TISA500</i> <br/>MD ‐0.02 (95% CI ‐0.06 to 0.02; 1 study, 64 eyes) at 6 months; </p> <p><i>TISA750</i><br/>MD ‐0.03 (95% CI ‐0.17 to 0.11; 1 study, 64 eyes) at 6 months; </p> <p><i>SSA</i><br/>MD ‐1.59 (95% CI ‐6.75 to 3.57; 1 study, 64 eyes) at 6 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Best corrected visual acuity</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.03 (95% CI ‐0.77 to 4.84) at 12 months;</p> <p>MD 4.30 (95% CI 0.74 to 7.87) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.01 (95% CI ‐0.10 to 0.08; 91 eyes) postoperatively</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.03 (95% CI ‐0.18 to 0.12; 1 study, 63 eyes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Adverse effects</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Phacoemulsification group:</i> </p> <p>malignant glaucoma (1 eye);</p> <p>irreversible loss of vision of more than 10 ETDRS letters (1 eye);</p> <p>other related adverse events (1 eye).</p> <p><i>LPI group:</i> </p> <p>lost ten or more ETDRS letters irreversibly (3 eyes);</p> <p>other related adverse events (10 eyes).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Phaco‐GSL group</i> </p> <p>hyphema (3 eyes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Less risk of:</p> <p>Intra‐ and post‐operative complications (RR 0.59, 95% CI 0.34 to 1.04);</p> <p>additional IOP‐lowering procedures (RR 5.81, 95% CI 1.41 to 23.88) in the phacoemulsification group </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>none</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of life measures</b> </p> <p><b>(European Quality of Life‐5 Dimension)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.03 (95% CI ‐0.16 to 0.22) at 6 months;</p> <p>MD 0.04 (95% CI ‐0.16 to 0.24) at 12 months;</p> <p>MD 0.005 (95% CI ‐0.19 to 0.20) at 24 months;</p> <p>MD ‐0.04 (95% CI ‐0.24 to 0.16) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>AOD:</b> angle opening distance; <b>CI:</b> confidence interval; <b>IOP:</b> Intraocular pressure; <b>NR:</b> not reported; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>RR:</b> risk ratio; <b>SSA:</b> scleral spur angle; <b>TISA:</b> trabecular iris space area </p> </div> </div> <section id="CD005555-sec-0064"> <h4 class="title">Phacoemulsification versus laser peripheral iridotomy (LPI)</h4> <p>One study compared phacoemulsification with standard care (LPI) in participants with both PAC and PACG without cataracts (i.e. clear lens extraction) (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>). We obtained the raw study data and repeated the analysis for participants with PACG only, using the statistical analysis plan published and provided by the trial investigators. We include a caveat here: the following results should be interpreted with caution because the study was not powered to investigate participants with PACG alone, and we have adjusted the GRADE score accordingly. Of those with PACG, 127 eyes underwent phacoemulsification and 136 had LPI. See <a href="./full#CD005555-tbl-0001">summary of findings Table 1</a>. </p> <section id="CD005555-sec-0065"> <h5 class="title">Primary outcomes</h5> <section id="CD005555-sec-0066"> <h6 class="title">Progression of visual field loss</h6> <p>The proportion of participants with evidence of progression of visual field loss was lower in the phacoemulsification group than the LPI group at six months (odds ratio [OR] 0.49, 95% confidence interval [CI] 0.24 to 0.92; 216 eyes), 12 months (OR 0.35, 95% CI 0.13 to 0.91; 216 eyes), 24 months (OR 0.37, 95% CI 0.17 to 0.82; 216 eyes), and 36 months (OR 0.42, 95% CI 0.20 to 0.87; 216 eyes). We graded the certainty of the evidence as moderate, having downgraded one level for imprecision (‐1) because the study cohort was not adequately powered to evaluate participants with PACG alone. </p> </section> <section id="CD005555-sec-0067"> <h6 class="title">Mean change in IOP from baseline to one year</h6> <p>There was no observable difference in change from baseline IOP between the intervention groups at any time point. The mean difference between the groups was ‐0.65 mmHg (95% CI ‐3.12 to 1.82; 257 eyes) at 6 months; ‐0.03 mmHg (95% CI ‐2.34 to 2.32; 257 eyes) at 12 months; 0.74 mmHg (95% CI ‐1.66 to 3.13; 257 eyes) at 24 months; and 1.04 mmHg (95% CI ‐1.22 to 3.31; 257 eyes) at 36 months. We graded the certainty of evidence as moderate for this outcome, downgrading one level for imprecision (‐1) because the study cohort was not adequately powered to evaluate participants with PACG alone. </p> </section> </section> <section id="CD005555-sec-0068"> <h5 class="title">Secondary outcomes</h5> <section id="CD005555-sec-0069"> <h6 class="title">Mean change in depth of the anterior chamber</h6> <p>Not reported.</p> </section> <section id="CD005555-sec-0070"> <h6 class="title">Number of medications used to control IOP</h6> <p>The phacoemulsification group required fewer IOP‐lowering medications than the LPI group at 6 months (mean difference [MD] ‐0.65, 95% CI ‐0.85 to ‐0.45; 263 eyes); 12 months (MD ‐0.70, 95% CI ‐0.89 to ‐0.51; 263 eyes); 24 months (MD ‐0.73, 95% CI ‐0.94 to ‐0.52; 263 eyes); and 36 months (MD ‐0.65, 95% CI ‐0.87 to ‐0.43; 263 eyes). We graded the certainty of evidence as moderate for this outcome, downgrading one level for imprecision (‐1) because the study cohort was not adequately powered to evaluate participants with PACG alone. </p> </section> <section id="CD005555-sec-0071"> <h6 class="title">Gonioscopic findings</h6> <p>Gonioscopic findings favored the phacoemulsification group, which had less appositional angle closure at 12 months (MD ‐84.93°, 95% CI ‐131.25° to ‐38.61°; 106 eyes) and 36 months (MD ‐74.16°, 95% CI ‐121.34° to ‐26.98°; 101 eyes) compared to the LPI group. The phacoemulsification group also had less synechial angle closure (extent of PAS) at 12 months (MD ‐69.63°, 95% CI ‐104.34° to ‐16.92°, 51 eyes) compared to the LPI group, with similar outcomes at 36 months (MD 1.12°, 95% CI ‐42.37° to 44.62°, 52 eyes). We graded the certainty of evidence as moderate for this outcome, downgrading one level for imprecision (‐1) because the study cohort was not adequately powered to evaluate participants with PACG alone. </p> </section> <section id="CD005555-sec-0072"> <h6 class="title">Visual acuity</h6> <p>Best corrected visual acuity, measured using the Early Treatment Diabetic Retinopathy Study (EDTRS) letter chart, was comparable between the groups at 12 months (MD 2.03, 95% CI ‐0.77 to 4.84; 242 eyes) but favored the LPI group at 36 months (MD 4.30, 95% CI 0.74 to 7.87; 242 eyes). We graded the certainty of evidence as low for this outcome, downgrading by one level because of imprecision (‐1) because the study cohort was not adequately powered to evaluate participants with PACG alone. </p> </section> <section id="CD005555-sec-0073"> <h6 class="title">Adverse effects</h6> <p>At six months, malignant glaucoma was reported in one eye of one participant in each of the phacoemulsification and LPI groups; irreversible loss of vision of more than ten ETDRS letters was reported in one eye of one participant in the phacoemulsification group; and other related adverse events were reported in five eyes in the phacoemulsification group, and three eyes in the LPI group. The analysis included 118 eyes of 118 participants in the phacoemulsification group, and 132 eyes of 132 participants in the LPI group for all outcomes except malignant glaucoma (117 eyes in 117 participants in the phacoemulsification group and 131 eyes in 131 participants in the LPI group), and other related adverse events (81 eyes in 81 participants in the phacoemulsification group, and 92 eyes in 92 participants in the LPI group). </p> <p>At 36 months, malignant glaucoma was reported in one eye of one participant in the phacoemulsification group, irreversible loss of vision of more than ten ETDRS letters was reported in one eye of one participant in the phacoemulsification group and three eyes of three participants in the LPI group, and other related adverse events were reported in one eye in the phacoemulsification group and ten eyes in the LPI group. The analysis included 112 eyes of 112 participants in the phacoemulsification group and 121 eyes of 121 participants in the LPI group for all outcomes except other related adverse events (85 eyes of 85 participants in the phacoemulsification group and 88 eyes in 88 participants in the LPI group). </p> <p>We graded the certainty of evidence as moderate for this outcome, downgrading by one level because of imprecision (‐1). </p> </section> <section id="CD005555-sec-0074"> <h6 class="title">Quality of life measures</h6> <p>The study used the European Quality of Life‐5 Dimension (EQ‐5D), with three rating scales in five dimensions of health, to assess health status; higher score means better quality of life. There was no evidence of difference between the two groups at 6 months (MD 0.03, 95% CI ‐0.16 to 0.22; 254 eyes), 12 months (MD 0.04, 95% CI ‐0.16 to 0.24; 254 eyes), 24 months (MD 0.005, 95% CI ‐0.19 to 0.20; 254 eyes), or 36 months (MD ‐0.04, 95% CI ‐0.24 to 0.16; 254 eyes). We graded the certainty of evidence as moderate, downgraded by one level because of imprecision (‐1). </p> </section> </section> </section> <section id="CD005555-sec-0075"> <h4 class="title">Phacoemulsification versus phacoemulsification with viscogonioplasty (phaco‐VGP)</h4> <p><a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a> compared phacoemulsification and phaco‐VGP in eyes with PACG and co‐existing cataracts, reporting the results for 46 eyes in the phacoemulsification group and 45 in the phaco‐VGP group for participants who had completed at least 12 months of follow‐up. See <a href="./full#CD005555-tbl-0002">summary of findings Table 2</a>. </p> <section id="CD005555-sec-0076"> <h5 class="title">Primary outcomes</h5> <section id="CD005555-sec-0077"> <h6 class="title">Progression of visual field loss</h6> <p>Not reported.</p> </section> <section id="CD005555-sec-0078"> <h6 class="title">Mean change in IOP from baseline to one year</h6> <p>Reduction in IOP was observed in both the phacoemulsification (‐8.3 mmHg ± 6.8 mmHg) and phaco‐VGP (‐8.8 mmHg ± 8.4 mmHg) groups at one year; there was no evidence of difference between groups (MD 0.50 mmHg, 95% CI ‐2.64 to 3.64; 91 eyes; <a href="./references#CD005555-fig-0003" title="">Analysis 1.1</a>). We graded the certainty of evidence as low for this outcome, downgrading by two levels because of high risk of attrition bias (‐1) and imprecision due to wide confidence intervals (‐1). </p> </section> </section> <section id="CD005555-sec-0079"> <h5 class="title">Secondary outcomes</h5> <section id="CD005555-sec-0080"> <h6 class="title">Mean change in depth of the anterior chamber</h6> <p>Not reported.</p> </section> <section id="CD005555-sec-0081"> <h6 class="title">Number of medications used to control IOP</h6> <p>Fewer IOP‐lowering medications were used in the phacoemulsification group (0.1 ± 0.4) compared to the phaco‐VGP group (0.4 ± 0.8) at 6 months (MD ‐0.30, 95% CI ‐0.56 to ‐0.04; 91 eyes; <a href="./references#CD005555-fig-0004" title="">Analysis 1.2</a>), and 12 months (0.1 ± 0.3 versus 0.4 ± 0.8; MD ‐0.30, 95% CI ‐0.55 to ‐0.05; 91 eyes; <a href="./references#CD005555-fig-0004" title="">Analysis 1.2</a>). We graded the certainty of evidence as low for this outcome, downgrading by two levels because of high risk of attrition bias (‐1) and wide confidence intervals (‐1). </p> </section> <section id="CD005555-sec-0082"> <h6 class="title">Gonioscopic findings</h6> <p>There was increased angle width in both the phacoemulsification and phaco‐VGP groups, which was higher in the phaco‐VGP group (1.4 ± 0.8 versus 2.0 ± 0.7; MD ‐0.60, 95% CI ‐0.91 to ‐0.29; 91 eyes; <a href="./references#CD005555-fig-0005" title="">Analysis 1.3</a>). This was measured at the last follow‐up visit (at 12 months or later) which varied for each individual. </p> <p>Changes in anterior segment optical coherence tomography (AS‐OCT) parameters were also described: both phacoemulsification and phaco‐VGP groups had changes in the trabecular iris space area (TISA500 [0.020 ± 0.084 versus 0.054 ± 0.033]) and TISA750 (0.084 ± 0.057 versus 0.119 ± 0.061) at 12 months; this increase was higher in the phaco‐VGP group (MD ‐0.03, 95% CI ‐0.06 to ‐0.01 in TISA500, and MD ‐0.03, 95% CI ‐0.06 to ‐0.01 in TISA750; 91 eyes; <a href="./references#CD005555-fig-0005" title="">Analysis 1.3</a>). We graded the certainty of evidence as low for this outcome, downgrading by two levels because of high risk of attrition bias (‐1) and imprecision due to wide confidence intervals (‐1). </p> </section> <section id="CD005555-sec-0083"> <h6 class="title">Visual acuity</h6> <p>The mean logMAR best‐corrected visual acuity (BCVA) was comparable at baseline (0.49 ± 0.28 in the phacoemulsification group versus 0.49 ± 0.35 in the phaco‐VGP group; MD 0.00, 95% CI ‐0.13 to 0.13; 91 eyes), and postoperatively (0.27 ± 0.2 in the phacoemulsification group versus 0.28 ± 0.23 in the phaco‐VGP group; MD ‐0.01, 95% CI ‐0.10 to 0.08; 91 eyes; <a href="./references#CD005555-fig-0006" title="">Analysis 1.4</a>). We graded the certainty of evidence as moderate for this outcome, downgrading by two levels due to high risk of attrition bias (‐1) and imprecision from wide confidence intervals (‐1). </p> </section> <section id="CD005555-sec-0084"> <h6 class="title">Adverse effects</h6> <p>Three participants in the phaco‐VGP group developed postoperative hyphema that was successfully managed with viscotamponade. Four participants in the phaco‐VGP group and two in the phacoemulsification alone group developed a postoperative fibrin reaction that resolved after a few days. No other adverse effects were reported. </p> </section> <section id="CD005555-sec-0085"> <h6 class="title">Quality of life measures</h6> <p>Not measured.</p> </section> </section> </section> <section id="CD005555-sec-0086"> <h4 class="title">Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL)</h4> <p>Two studies compared phacoemulsification alone with combined phaco‐GSL (<a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>). <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> comprised 30 eyes in the phacoemulsification group and 34 in the phaco‐GSL group. <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a> included participants with both PAC and PACG with and without a previous history of acute angle closure attacks. We obtained the raw study data from the lead author and repeated the analysis for only participants with PACG without previous acute angle closure attacks. This gave us 16 eyes in the phacoemulsification group and 16 in the phaco‐GSL group. We were unable to conduct any meta‐analyses because the outcomes were measured at different time points in both studies. See <a href="./full#CD005555-tbl-0003">summary of findings Table 3</a>. </p> <section id="CD005555-sec-0087"> <h5 class="title">Primary outcomes</h5> <section id="CD005555-sec-0088"> <h6 class="title">Progression of visual field loss</h6> <p>Not reported by either study.</p> </section> <section id="CD005555-sec-0089"> <h6 class="title">Mean change in IOP from baseline to one year</h6> <p><a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> did not report the mean change in IOP from baseline. However, there was no evidence of difference in mean IOP at six months between the phacoemulsification and phaco‐GSL groups (13.17 mmHg ± 1.66 mmHg versus 13.21 mmHg ± 1.97 mmHg; MD ‐0.04 mmHg, 95% CI ‐0.93 to 0.85; 64 eyes; <a href="./references#CD005555-fig-0007" title="">Analysis 2.1</a>). We graded the certainty of evidence as low for this outcome, downgrading by one level each because of high risk of attrition bias (‐1) and imprecision due to wide confidence intervals (‐1). </p> <p>In <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>, the mean change in IOP from baseline to 12 months was comparable between the phacoemulsification and phaco‐GSL groups (‐6.59 mmHg ± 6.72 mmHg versus ‐6.47 mmHg ± 6.57 mmHg; MD ‐0.12 mmHg, 95% CI ‐4.72 to 4.48; 32 eyes; <a href="./references#CD005555-fig-0007" title="">Analysis 2.1</a>). We graded the certainty of evidence as moderate for this outcome, downgrading by one level because of imprecision due to wide confidence intervals (‐1). </p> </section> </section> <section id="CD005555-sec-0090"> <h5 class="title">Secondary outcomes</h5> <section id="CD005555-sec-0091"> <h6 class="title">Mean change in depth of the anterior chamber</h6> <p>Not reported by either study.</p> </section> <section id="CD005555-sec-0092"> <h6 class="title">Number of medications used to control IOP</h6> <p>In <a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>, the phacoemulsification group required fewer IOP‐lowering medications at six months compared to the phaco‐GSL group (1.70 ± 0.66 versus 2.05 ± 0.46; MD ‐0.35, 95% CI ‐0.63 to ‐0.07; 64 eyes; <a href="./references#CD005555-fig-0008" title="">Analysis 2.2</a>). We graded the certainty of evidence as low for this outcome, downgrading by one level each because of high risk of attrition bias (‐1) and imprecision due to small sample size (‐1). </p> <p>In <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>, the phacoemulsification and phaco‐GSL groups required a comparable number of IOP‐lowering medications at 12 months (0.56 ± 1.09 versus 0.94 ± 1.34; MD ‐0.38, 95% CI ‐1.23 to 0.47; 32 eyes; <a href="./references#CD005555-fig-0008" title="">Analysis 2.2</a>). We graded the certainty of evidence as moderate for this outcome, downgrading by one level because of imprecision due to wide confidence intervals (‐1). </p> </section> <section id="CD005555-sec-0093"> <h6 class="title">Gonioscopic findings</h6> <p><a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> described the iridocorneal angle changes in terms of quantitative anterior segment optical coherence tomography (AS‐OCT) findings at six months postoperatively. While there was an improvement in angle opening for both groups, there was no evidence of difference for the five parameters, measured between the phacoemulsification and phaco‐GSL groups: angle opening distance (AOD)500 (0.48 ± 0.21 versus 0.52 ± 0.65; MD ‐0.04, 95% CI ‐0.27 to 0.19; 64 eyes); AOD750 (0.72 ± 0.3 versus 0.71 ± 0.77; MD 0.01, 95% CI ‐0.27 to 0.29; 64 eyes); trabecular iris space area (TISA)500 (0.15 ± 0.06 versus 0.17 ± 0.10; MD ‐0.02, 95% CI ‐0.06 to 0.02; 64 eyes); TISA750 (0.30 ± 0.12 versus 0.33 ± 0.40; MD ‐0.03, 95% CI ‐0.17 to 0.11; 64 eyes); scleral spur angle (SSA) (31.47 ± 10.84 versus 33.06 ± 10.11; MD ‐1.59, 95% CI ‐6.75 to 3.57; 64 eyes; <a href="./references#CD005555-fig-0009" title="">Analysis 2.3</a>). </p> <p><b>Visual acuity</b> </p> <p>Not reported by either study.</p> </section> <section id="CD005555-sec-0094"> <h6 class="title">Adverse effects</h6> <p><a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a> reported three cases of postoperative hyphema in the phaco‐GSL group. These data were not available for the subgroup in <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a>. </p> <p><b>Quality of life measures</b> </p> <p>Not reported by either study.</p> </section> </section> </section> <section id="CD005555-sec-0095"> <h4 class="title">Phacoemulsification versus combined phaco‐trabeculectomy</h4> <p>Three studies compared phacoemulsification alone with phaco‐trabeculectomy in 63 eyes of 63 participants with chronic PACG (<a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>), 72 eyes of 72 participants with medically controlled chronic PACG with coexisting cataract (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>), and 51 eyes of 51 participants with medically uncontrolled chronic PACG with coexisting cataract (<a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>). The latter two studies also included participants with previous acute angle‐closure attacks. We requested the data for the subgroup of participants who did not have a history of acute angle‐closure attacks from the trial investigators, but could not incorporate them, because they only provided the data for the phacoemulsification group. This comprised 26 eyes (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>), and 20 eyes (<a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>) in the phacoemulsification groups that did not have a previous acute angle‐closure attack. Participants who did not complete the 12‐month follow‐up were excluded from analysis (number unknown). See <a href="./full#CD005555-tbl-0004">summary of findings Table 4</a>. </p> <section id="CD005555-sec-0096"> <h5 class="title">Primary outcomes</h5> <section id="CD005555-sec-0097"> <h6 class="title">Progression of visual field loss</h6> <p>One (3.8%) participant (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>), and 10 (50%) participants (<a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>) in the phacoemulsification groups had progression of visual field loss at 24 months. Visual field loss was not reported by <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>. </p> </section> <section id="CD005555-sec-0098"> <h6 class="title">Mean change in IOP from baseline to one year</h6> <p>The mean IOP at 12 months in the phacoemulsification groups was 14.2 mmHg ± 2.8 mmHg in <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>, and 15.8 mmHg ± 3.4 mmHg in <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>. </p> <p><a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> did not report the mean change in IOP from baseline. The mean IOP between the phacoemulsification and phaco‐trabeculectomy groups were statistically similar at baseline (21.6 mmHg ± 9.2 mmHg in phacoemulsification group versus 25.6 mmHg ± 11.1 mmHg in phaco‐trabeculectomy group; MD ‐4.00 mmHg, 95% CI ‐9.04 to 1.04; 63 eyes). The mean IOP remained statistically comparable at all time points measured postoperatively: at 1 month (14.4 mmHg ± 3.6 mmHg versus 13.9 mmHg ± 6.0 mmHg; MD 0.50 mmHg, 95% CI ‐1.95 to 2.95; 63 eyes), 3 months (13.0 mmHg ± 5.4 mmHg versus 13 mmHg ± 4.1 mmHg; MD 0.00 mmHg, 95% CI ‐2.36 to 2.36; 63 eyes), 6 months (12.4 mmHg ± 2.5 mmHg versus 12.7 mmHg ± 3.8 mmHg; MD ‐0.30 mmHg, 95% CI ‐1.89 to 1.29; 63 eyes), and 12 months (12.6 mmHg ± 2.6 mmHg versus 13.2 mmHg ± 3.0 mmHg; MD ‐0.60 mmHg, 95% CI ‐1.99 to 0.79; 63 eyes; <a href="./references#CD005555-fig-0010" title="">Analysis 3.1</a>). We graded the certainty of evidence as low for this outcome, downgrading by one level each because of high risk of attrition bias (‐1) and imprecision due to wide confidence intervals (‐1). </p> </section> <section id="CD005555-sec-0099"> <h6 class="title">Mean change in depth of the anterior chamber (ACD)</h6> <p>The ACD data was not available for the subgroup of participants without previous acute angle‐closure attacks in <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a> and <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>, and was not reported by <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>. </p> </section> </section> <section id="CD005555-sec-0100"> <h5 class="title">Secondary outcomes</h5> <section id="CD005555-sec-0101"> <h6 class="title">Number of medications used to control IOP</h6> <p>In <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>, the mean number of IOP‐lowering medications was 2.3 (SD 0.9) in the phacoemulsification group and 2.8 (SD 1) in the phaco‐trabeculectomy group preoperatively. This was lower in the phaco‐trabeculectomy group than the phacoemulsification group at 1 month (0.1 ± 0.2 versus 0.4 ± 0.8; MD 0.30, 95% CI 0.01 to 0.59; 63 eyes), and at 3 months (0.1 ± 0.4 versus 0.5 ± 0.9; MD 0.40, 95% CI 0.06 to 0.74; 63 eyes); but comparable between groups at 6 months (0.5 ± 0.8 in the phacoemulsification group versus 0.3 ± 0.6 in the phaco‐trabeculectomy group; MD 0.20, 95% CI ‐0.15 to 0.55; 63 eyes), and 12 months (0.5 ± 0.8 versus 0.5 ± 0.9; MD 0.00, 95% CI ‐0.42 to 0.42; 63 eyes; <a href="./references#CD005555-fig-0011" title="">Analysis 3.2</a>). </p> <p>The number of IOP‐lowering medications was not available for the subgroup of participants without previous acute angle‐closure attacks in <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a> or <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>. </p> <p>We graded the certainty of evidence as low for this outcome, downgrading by one level each because of high risk of attrition bias (‐1) and imprecision due to wide confidence intervals (‐1). </p> </section> <section id="CD005555-sec-0102"> <h6 class="title">Gonioscopic findings</h6> <p>Gonioscopic findings were not available for the subgroup of participants without previous acute attacks of angle closure in <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a> and <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>, and were not reported by <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>. </p> </section> <section id="CD005555-sec-0103"> <h6 class="title">Visual acuity</h6> <p>For <a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>, the best corrected visual acuity was comparable between the phacoemulsification and phaco‐trabeculectomy groups at baseline (0.29 ± 0.3 versus 0.27 ± 0.25; MD 0.02, 95% CI ‐0.12 to 0.16; 63 eyes), and at the final follow‐up visit (variable time scale for each participant) (0.35 ± 0.31 versus 0.38 ± 0.3; MD ‐0.03, 95% CI ‐0.18 to 0.12; 63 eyes; <a href="./references#CD005555-fig-0012" title="">Analysis 3.3</a>). </p> <p>Visual acuity data were not available for the subgroup of participants without previous acute angle‐closure attacks in <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a> or <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>. </p> <p>We graded the certainty of evidence as low for this outcome, downgrading by one level each because of high risk of attrition bias (‐1) and imprecision due to wide confidence intervals (‐1). </p> </section> <section id="CD005555-sec-0104"> <h6 class="title">Adverse effects</h6> <p><a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> reported that the phacoemulsification group experienced fewer complications than the phaco‐trabeculectomy group overall (risk ratio [RR] 0.59, 95% CI 0.34 to 1.04; 63 eyes; <a href="./references#CD005555-fig-0013" title="">Analysis 3.4</a>). Phacoemulsification resulted in one case of intraoperative posterior capsular tear with vitreous loss, nine of corneal edema, and one of pupillary membrane; whereas, phaco‐trabeculectomy resulted in 18 complications, including intraoperative hyphema (1), corneal edema (6), corneal ulcer (1), hypotony (3), choroidal detachment (1), conjunctival retraction (1), shallow anterior chamber (2), pupillary membrane (2), and wipe‐out (1). In addition, more eyes in the phaco‐trabeculectomy group required further IOP‐lowering procedures (eleven needed one or more needle bleb revisions, and one underwent cyclodiode laser) than the phacoemulsification group (two eyes required trabeculectomy) (RR 5.81, 95% CI 1.41 to 23.88; 63 eyes; <a href="./references#CD005555-fig-0013" title="">Analysis 3.4</a>). </p> <p>Two of 26 eyes in <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a> and two of 20 eyes in <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a> had intraoperative complications in the phacoemulsification group. They did not observe any postoperative complications. </p> <p>We graded the certainty of evidence as low for this outcome, downgrading by one level each because of high risk of attrition bias (‐1) and imprecision due to wide confidence intervals (‐1). </p> <p><b>Quality of life measures</b> </p> <p>Not reported by any study.</p> </section> </section> </section> <section id="CD005555-sec-0105"> <h4 class="title">Phacoemulsification versus trabeculectomy</h4> <p><a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a> compared phacoemulsification with trabeculectomy in participants with medically uncontrolled chronic angle‐closure glaucoma without cataract. We obtained the data for a subgroup of participants without history of acute angle‐closure attacks from the trial investigators. Of 26 participants originally randomized to phacoemulsification, 16 did not have previous acute attacks. The data in the trabeculectomy group were not provided, and as such, we were unable to analyze the between‐group differences. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005555-sec-0106" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005555-sec-0106"></div> <section id="CD005555-sec-0107"> <h3 class="title" id="CD005555-sec-0107">Summary of main results</h3> <p>We identified eight randomized controlled trials (RCT) comprising 513 eyes (total number of participants unknown) that addressed the utility of lens extraction in treating chronic angle‐closure glaucoma. The participants were recruited from a diverse range of countries and were followed up for a minimum of 12 months. </p> <p>One RCT compared phacoemulsification with laser peripheral iridotomy (LPI) in chronic primary angle‐closure glaucoma (PACG) with clear crystalline lenses. A smaller proportion of participants who had phacoemulsification experienced progression of visual field loss than those who had LPI at 12 months. There was greater widening of the iridocorneal angle in participants in the phacoemulsification group compared with those in the LPI group, but no evidence of difference in intraocular pressure (IOP) reduction at all time points up to 3 years. However, the phacoemulsification group required fewer IOP‐lowering medications to achieve this reduction. There was no evidence of difference between phacoemulsification and LPI for health‐related quality of life, or for adverse events in the hands of experienced surgeons. All these findings, together with moderate certainty of evidence, suggest a clinical benefit to phacoemulsification over LPI. It is also important to note that this study was not powered to look only at those with PACG and this is a sub‐analysis; lack of significance for some findings could be perhaps be attributed to the small sample size. In addition, these results are applicable over a three‐year time period, and longer term comparisons are not yet known. </p> <p>Only one study compared phacoemulsification with trabeculectomy, but we did not have the data to analyze and draw conclusions. </p> <p>Three studies compared phacoemulsification with phacoemulsification and trabeculectomy. There were limited data on progression of visual field loss, change in ACD, or iridocorneal angle within these studies. There was no evidence of difference between groups for IOP, or the number of medications used to control IOP. However, there was evidence that phacoemulsification was associated with a reduced risk of complications compared with phacoemulsification plus trabeculectomy in one trial (<a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a>) (low certainty of evidence). </p> <p>The remaining three studies compared phacoemulsification alone versus phacoemulsification (phaco) plus supplemental interventions (viscogonioplasty [VGP] or goniosynechialysis [GSL]). All these trials included 6‐month or 12‐month follow‐up. There were no data on progression of visual field loss in these trials. Moderate to low certainty evidence suggest that there may be little or no evidence of additional benefit with the supplemental procedures compared with phacoemulsification alone for reducing IOP or medications to control IOP, increasing width of the iridocorneal angle, or visual acuity. While more complications were reported among participants in the phacoemulsification plus supplemental procedure groups than in the phacoemulsification groups, there were insufficient data to draw conclusions with certainty. Until further evidence becomes available, these supplemental procedures may be left to the discretion of the surgeon or local protocols. </p> </section> <section id="CD005555-sec-0108"> <h3 class="title" id="CD005555-sec-0108">Overall completeness and applicability of evidence</h3> <p>Overall, the review possesses good external validity. The definition of chronic PACG used in each study was generally similar across the board. The overall study population appropriately reflected the real‐world distribution of PACG. In addition, participants included those with medically controlled and uncontrolled PACG, which is similarly a representative microcosm of the wider population with PACG. The eight studies reported on chronic PACG patients with cataractous as well as clear lenses, providing a broad perspective on the utility of lens extraction in PACG. The studies encompassed a wide range of clinically relevant interventions, including one that compared lens extraction against standard care, enabling the evaluation of lens extraction's true effectiveness as a treatment modality. The majority of the included studies assessed both IOP measurements and IOP‐lowering medications, which are clinically important in terms of arresting glaucoma progression. However, the ultimate goal of PACG treatment is also to prevent additional damage to the optic nerve in order to slow or arrest visual field loss, and IOP alone may not be sufficient to assess this. Even so, few studies included progression of visual field loss as an outcome measure. In addition, the impact of the interventions on participants' health‐related quality of life was not always sought. Future studies will want to consider assessing the impact of interventions on both visual field and quality of life. </p> <p>The potential differences between RCT and real world outcomes is also worth noting. Compared to a routine phacoemulsification case, eyes with PACG tend to have anatomical differences including shallower anterior chambers, shorter axial lengths, and thicker and more anteriorly positioned crystalline lenses, among others. Phacoemulsification in PACG eyes may therefore be a more challenging endeavour, thereby increasing the innate risks of intraoperative complications. While it is reassuring that the complication rates in the included studies were rates were modest, an important caveat to note is that these surgeries were invariably performed by highly experienced surgeons, whereas this may not necessarily hold true in a real world setting. </p> <p>Finally, where outcomes of interest were inadequately reported, we wrote to the study authors to seek further clarification, and thereby, ensure that the review was as complete as possible. However, we were regrettably unable to obtain comparative data for three studies, and complete safety data for a few others (<a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>; <a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a>). </p> </section> <section id="CD005555-sec-0109"> <h3 class="title" id="CD005555-sec-0109">Quality of the evidence</h3> <p>The quality of evidence varied among the included studies. We graded the certainty of evidence to be moderate or low due to risk of bias and imprecision related to the small number of participants included in each comparison of interventions. Although randomization was adequate and there were minimal conflicts of interest across the board, the remaining risk of bias domains were problematic, primarily due to poor adherence to the CONSORT guidelines (<a href="./references#CD005555-bbs2-0082" title="MoherD , HopewellS , SchulzKF , MontoriV , GøtzschePC , DevereauxPJ , et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ2010;340:c869.">Moher 2010</a>). Allocation concealment and masking were generally poorly reported. In addition, loss to follow‐up was inadequately documented, and three studies lacked intention‐to‐treat analyses, instead excluding missing patients entirely. For the comparison of phacoemulsification and phaco‐VGP or phaco‐GSL in particular, variability in outcome reporting also hampered the synthesis of information. All these reduce confidence in the validity of the findings, which should therefore be interpreted with caution. </p> </section> <section id="CD005555-sec-0110"> <h3 class="title" id="CD005555-sec-0110">Potential biases in the review process</h3> <p>The review team used standard Cochrane methodology, including a comprehensive search strategy designed by experienced information specialists. Two review authors, including at least one clinician and one methodologist, independently assessed the search results for eligibility and extracted data. In addition, we reached out to the authors to seek clarification on the eligibility of the study for inclusion, as well as points of contention. As there were no language restrictions, multiple publications available only in Chinese were carefully reviewed in the screening process, which was important because a fair proportion of people with PACG reside in Chinese‐speaking regions. As such, we can confidently conclude that we have identified most, if not all, pertinent results in this review. However, it is important to note that the results should be interpreted with caution, as we obtained data for participants meeting our inclusion criteria only (chronic PACG, no previous acute angle‐closure attacks) to conduct several analyses, meaning that the data might not be adequately powered to answer the clinical question posed. </p> <p>One of the review authors (DSF) co‐authored one study included in this review (<a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a>). However, two other review authors (AYO and SMN) independently assessed the study eligibility, extracted the data, and judged risk of bias following Cochrane standard methodology, and a third (VSS) performed the statistical analyses for this study. We consider the risk of bias induced by this association to be minimal. </p> </section> <section id="CD005555-sec-0111"> <h3 class="title" id="CD005555-sec-0111">Agreements and disagreements with other studies or reviews</h3> <p>This review demonstrates evidence for the benefits of lens extraction in terms of improving IOP control, increasing ACD, and reducing the number of IOP‐lowering medications required in people with chronic PACG. This is consistent with findings from previous non‐comparative studies, which demonstrated similar IOP reduction and increased ACD after lens extraction in participants with PACG, primary angle closure (PAC), or even normal non‐glaucomatous eyes (<a href="./references#CD005555-bbs2-0065" title="AtalayE , NongpiurME , BaskaranM , PereraSA , WongTT , QuekD , et al. Intraocular pressure change after phacoemulsification in angle-closure eyes without medical therapy. Journal of Cataract and Refractive Surgery2017;43(6):767-73.">Atalay 2017</a>; <a href="./references#CD005555-bbs2-0078" title="KashiwagiK , KashiwagiF , TsukaharaS . Effects of small-incision phacoemulsification and intraocular lens implantation on anterior chamber depth and intraocular pressure. Journal of Glaucoma2006;15(2):103-9.">Kashiwagi 2006</a>; <a href="./references#CD005555-bbs2-0094" title="SiakJ , QuekD , NongpiurME , HoSW , HtoonHM , PereraS ,  et al. Anterior chamber angle and intraocular pressure changes after phacoemulsification: a comparison between eyes with closed-angle and open-angle glaucoma. Journal of Glaucoma2016;25(3):e259-64.">Siak 2016</a>). <a href="./references#CD005555-bbs2-0081" title="MasisM , MineaultPJ , PhanE , LinSC . The role of phacoemulsification in glaucoma therapy: a systematic review and meta-analysis. Survey of Ophthalmology2017;63(5):700-10.">Masis 2017</a> published a systematic meta‐analysis of the final change in IOP following phacoemulsification in 597 eyes with PACG. They reported an absolute change of ‐6.4 mmHg (95% confidence interval [CI] ‐9.4 to ‐3.4; IV = 99%) at the final follow‐up visit. While synthesizing these results to determine the absolute effect of phacoemulsification was out of the scope of this review, it is worth mentioning that <a href="./references#CD005555-bbs2-0081" title="MasisM , MineaultPJ , PhanE , LinSC . The role of phacoemulsification in glaucoma therapy: a systematic review and meta-analysis. Survey of Ophthalmology2017;63(5):700-10.">Masis 2017</a> included a mix of retrospective and prospective non‐randomized studies in addition to RCTs. Further, participants with previous acute angle‐closure attacks were eligible for inclusion in the review, and IOP was measured at the final follow‐up visit, which would vary between participants, as well as across each study. While this lends credence to the hypothesis that the lens may indeed play an important role in the pathophysiology of chronic PACG, it is possible that the true effect may differ from that described. </p> <p>The role of goniosynechialysis is also worth discussing further. This review suggests that there may be little or no evidence of additional benefit with of supplemental goniosynechialysis or viscogonioplasty compared with phacoemulsification alone for reducing IOP or medications to control IOP, increasing width of the iridocorneal angle, or visual acuity. <a href="./references#CD005555-bbs2-0061" title="Iqbal Ike K Ahmed, Georges M Durr. Goniosynechialysis … to Release or Not to Release? That Is Not the Question. Ophthalmology Glaucoma 1 September 2019;2(5):277-279.">Ahmed 2019</a> reviewed a range of studies, including both comparative and non‐comparative studies, as well as participants with both PAC and PACG. <a href="./references#CD005555-bbs2-0061" title="Iqbal Ike K Ahmed, Georges M Durr. Goniosynechialysis … to Release or Not to Release? That Is Not the Question. Ophthalmology Glaucoma 1 September 2019;2(5):277-279.">Ahmed 2019</a> highlights the confounding effect that phacoemulsification may have in itself releasing peripheral anterior synechiae (PAS), the fact that a successful outcome depends not simply on performing the procedure, but also on the amount of residual PAS, and finally, the lack of sufficient intraoperative gonioscopy in establishing an accurate baseline and outcome in terms of PAS. These are all important considerations that should be considered in future studies, before dismissing goniosynechialysis or viscogonioplasty out of hand. </p> <p>In their systematic review and meta‐analysis comparing phacoemulsification, trabeculectomy, and phaco‐trabeculectomy in the treatment of 1495 eyes with PACG, <a href="./references#CD005555-bbs2-0071" title="DengBL , JiangC , MaB , ZhangWF , LuP , DuYY ,   et al. Surgical treatment for primary angle-closure glaucoma: a meta-analysis. International  Journal of Ophthalmology2011;4(3):223-7.">Deng 2011</a> concluded that phacotrabeculectomy was superior to both trabeculectomy and phacoemulsification in reducing IOP. <a href="./references#CD005555-bbs2-0101" title="WangF , WuZH . Phacoemulsification versus combined phacotrabeculectomy in the treatment of primary angle-closure glaucoma with cataract: a meta-analysis. International Journal of Ophthalmology2016;9(4):597-603.">Wang 2016</a> published a separate review and meta‐analysis comparing phacoemulsification and phaco‐trabeculectomy in 468 eyes, which concluded that phacoemulsification alone had a better effect on IOP reduction than phaco‐trabeculectomy. Interestingly, the studies included in <a href="./references#CD005555-bbs2-0101" title="WangF , WuZH . Phacoemulsification versus combined phacotrabeculectomy in the treatment of primary angle-closure glaucoma with cataract: a meta-analysis. International Journal of Ophthalmology2016;9(4):597-603.">Wang 2016</a> overlapped with that of <a href="./references#CD005555-bbs2-0071" title="DengBL , JiangC , MaB , ZhangWF , LuP , DuYY ,   et al. Surgical treatment for primary angle-closure glaucoma: a meta-analysis. International  Journal of Ophthalmology2011;4(3):223-7.">Deng 2011</a>. Our findings differ from the conclusions from both reviews – while we were unable to draw any meaningful conclusions regarding phacoemulsification<br/>and trabeculectomy, we found some evidence to suggest that there was no significant benefit for phaco‐trabeculectomy over phacoemulsification alone, with the former more likely to produce more complications and result in further interventions. There are several methodological differences worth noting here: both <a href="./references#CD005555-bbs2-0071" title="DengBL , JiangC , MaB , ZhangWF , LuP , DuYY ,   et al. Surgical treatment for primary angle-closure glaucoma: a meta-analysis. International  Journal of Ophthalmology2011;4(3):223-7.">Deng 2011</a> and <a href="./references#CD005555-bbs2-0101" title="WangF , WuZH . Phacoemulsification versus combined phacotrabeculectomy in the treatment of primary angle-closure glaucoma with cataract: a meta-analysis. International Journal of Ophthalmology2016;9(4):597-603.">Wang 2016</a> included non‐randomized retrospective studies, thereby increasing the potential for bias, and result in a less robust estimate of effect (<a href="./references#CD005555-bbs2-0087" title="ReevesBC , DeeksJJ , HigginsJPT , SheaB , TugwellP , WellsGA . Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Reeves 2019</a>). Finally, neither review downgraded for risk of bias in the included studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005555-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD005555-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD005555-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 1: Mean IOP change from baseline" data-id="CD005555-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 1: Mean IOP change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 2: Mean number of medications to control IOP" data-id="CD005555-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 2: Mean number of medications to control IOP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 3: Gonioscopic findings" data-id="CD005555-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 3: Gonioscopic findings </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 4: Mean visual acuity" data-id="CD005555-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP), Outcome 4: Mean visual acuity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL), Outcome 1: Mean IOP change from baseline" data-id="CD005555-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL), Outcome 1: Mean IOP change from baseline </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL), Outcome 2: Mean number of medications to control IOP" data-id="CD005555-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL), Outcome 2: Mean number of medications to control IOP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL), Outcome 3: Gonioscopic findings" data-id="CD005555-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL), Outcome 3: Gonioscopic findings </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 1: Mean IOP" data-id="CD005555-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 1: Mean IOP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 2: Mean number of medications to control IOP" data-id="CD005555-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 2: Mean number of medications to control IOP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 3: Mean visual acuity" data-id="CD005555-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 3: Mean visual acuity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005555-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/urn:x-wiley:14651858:media:CD005555:CD005555-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 4: Adverse effects" data-id="CD005555-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_t/tCD005555-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Phacoemulsification versus combined phaco‐trabeculectomy, Outcome 4: Adverse effects </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/media/CDSR/CD005555/image_n/nCD005555-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005555-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Phacoemulsification compared with laser peripheral iridotomy for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification compared with laser peripheral iridotomy for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle‐closure glaucoma </p> <p><b>Settings:</b> 30 hospital eye services in Australia (1), mainland China (1), Hong Kong (2), Malaysia (2), Singapore (2), and the UK (22) </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> laser peripheral iridotomy (LPI) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of eyes<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>laser peripheral iridotomy</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression of visual field loss</b> <br/>(worsening of one or more stages, according<br/>to the Glaucoma Staging System‐2) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>165 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>65 per 1000 (25 to 152 per 1000)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.35 (0.13 to 0.91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>216<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline to 12 months</b> <br/>(mmHg) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the control group was ‐6.48 mmHg</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the intervention group was 0.03 mmHg <b>higher</b> (95% CI ‐2.34 mmHg to 2.32 mmHg) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>257<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, the number of medications in the control group was 0.98</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>On average, the number of medications in the intervention group was 0.70 <b>lower</b> (95% CI ‐0.89 to ‐0.51) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>263<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> <br/>(Degree of angle closure) </p> <p><i>(at 12 months or later)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean angle closure in the control group was 203°</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean angle closure in the intervention group was 84.93° <b>less</b> (95% CI 38.61° to 131.25°) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visual acuity</b> <br/>(ETDRS letter chart) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean visual acuity in the control group was 77.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean visual acuity in the intervention group was 2.03 letters <b>greater</b> (95% CI ‐0.77 to 4.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>242<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b><br/>(measured on the EQ‐5D; higher = better) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The average score on the EQ‐5D in the control group was 2.88</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The average score on the EQ‐5D in the intervention group was 0.04 <b>higher</b> (95% CI ‐0.16 to 0.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>254</p> <p>(one study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>EQ‐5D</b>: European Quality of Life‐5 Dimension </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision because sample size was not adequately powered (original study was powered to investigate participants with both primary angle closure (PAC) and primary angle‐closure glaucoma (PACG), whereas only participants with PACG were included in this analysis). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Phacoemulsification compared with laser peripheral iridotomy for primary angle‐closure glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005555-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus viscogonioplasty for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification versus phacoemulsification plus viscogonioplasty for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle‐closure glaucoma </p> <p><b>Settings:</b> university hospital in Iran </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> phacoemulsification plus viscogonioplasty (phaco‐VGP) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification plus viscogonioplasty</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Progression of visual field loss</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline to 12 months</b> <br/>(mmHg) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the control group was ‐8.8 mmHg</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the intervention group was<br/>‐8.3 mmHg; on average, <b>0.50 mmHg higher</b> (95% CI ‐2.64 to 3.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the control group was 0.4</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the intervention groups was 0.1; on average, <b>0.30 fewer</b> (95% CI ‐0.55 to ‐0.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>at 6 months:</i> MD ‐0.30 (95% CI ‐0.56 to ‐0.04; 1 study, 91 eyes) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> <br/>(Spaeth grading system) </p> <p><i>(at 12 months or later)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change of angle grading in the control group was 2.0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change of angle grading in the intervention group was 1.4; on average, <b>0.60 less</b> (95% CI ‐0.91 to ‐0.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> (TISA500) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA500 in the control group was 0.054</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA500 in the intervention group was 0.020; on average, <b>0.03 less</b> (95% CI ‐0.06 to ‐0.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> (TISA750) </p> <p><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA750 in the control group was 0.119</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean TISA750 in the intervention group was 0.084; on average, <b>0.03 less</b> (95% CI ‐0.06 to ‐0.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visual acuity</b> <br/>(log MAR units) </p> <p><i>(postoperatively)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the control group was 0.28</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the intervention group was 0.27; on average, <b>0.01 less</b> (95% CI ‐0.10 to 0.08) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>91 eyes<br/>(one study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> <br/><i>(at 12 months)</i> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>hyphema (3 eyes), postoperative fibrin reaction (4 eyes)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>postoperative fibrin reaction (2 eyes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>IOP:</b> Intraocular pressure; <b>TISA:</b> trabecular iris space area </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for high risk of attrition bias<br/><sup>b</sup>Downgraded one level for imprecision due to wide confidence intervals </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus viscogonioplasty for primary angle‐closure glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005555-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus goniosynechialysis for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification versus phacoemulsification plus goniosynechialysis for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle closure glaucoma </p> <p><b>Settings:</b> tertiary eye care center and university hospital in Vietnam, Thailand, and Hong Kong </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> phacoemulsification plus goniosynechialysis (phaco‐GSL) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="middle"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification plus goniosynechialysis</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Progression of visual field loss</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline</b> <br/>(mmHg) </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the control group was ‐6.47 mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean change in IOP in the intervention group was ‐6.59; on average, <b>0.12 lower</b> (95% CI ‐4.72 to 4.48) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 eyes<br/>(one study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>at 6 months</i>: MD ‐0.04 mmHg (95% CI ‐0.93 to 0.85; 1 study, 64 eyes) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the control group was 0.94</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the intervention groups was 0.56; on average, <b>0.38 fewer</b> </p> <p>(95% CI ‐1.23 to 0.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 eyes<br/>(one study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>at 6 months</i>: MD ‐0.35 (95% CI ‐0.63 to ‐0.07; 1 study, 64 eyes) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> <br/>(Anterior segment optical coherence tomography parameters) </p> <p><i>(at 6 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comments</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64 eyes (one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AOD500: MD ‐0.04° (95% CI ‐0.27 to 0.19)</p> <p>AOD750: MD 0.01° (95% CI ‐0.27 to 0.29)</p> <p>TISA500: MD ‐0.02° (95% CI ‐0.06 to 0.02)</p> <p>TISA750: MD ‐0.03° (95% CI ‐0.17 to 0.11)</p> <p>SSA: MD ‐1.59° (95% CI ‐6.75 to 3.57)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visual acuity</b> <br/>(log MAR units) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> <br/><i>(at 6 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>hyphema (3 eyes)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>none reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>AOD:</b> angle opening distance; <b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>MD:</b> mean difference; <b>SSA:</b> scleral spur angle; <b>TISA:</b> trabecular iris space area </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level for imprecision due to wide confidence intervals </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus goniosynechialysis for primary angle‐closure glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005555-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus trabeculectomy for primary angle‐closure glaucoma</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Phacoemulsification versus phacoemulsification plus trabeculectomy for primary angle‐closure glaucoma</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> participants with primary angle‐closure glaucoma </p> <p><b>Settings:</b> university hospital in Egypt </p> <p><b>Intervention:</b> phacoemulsification </p> <p><b>Comparison:</b> phacoemulsification plus trabeculectomy </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty</b> of the evidence<br/>(GRADE) </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Phacoemulsification combined with trabeculectomy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Phacoemulsification</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Progression of visual field loss</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean IOP change from baseline to 12 months</b> <br/>(mmHg) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IOP in the control group was 13.2 mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean IOP in the intervention group was 12.6 mmHg; on average, <b>0.60 mmHg lower</b> </p> <p>(95% CI ‐1.99 to 0.79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean number of medications to control IOP</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the control group was 0.5</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean number of medications to control IOP in the intervention group was 0.5; on average, there was <b>no difference</b> (95% CI ‐0.42 to 0.42) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Gonioscopic findings</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean best corrected visual acuity</b> <br/>(on Snellen chart) </p> <p><i>(at final follow‐up)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the control group was 0.38</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean best corrected visual acuity in the intervention group was 0.35: on average, <b>0.03 lower</b> (95% CI ‐0.18 to 0.12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Adverse effects</b> <br/><i>(up to 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Intraoperative and postoperative complications</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.59</b> (0.34 to 1.04) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>63 eyes</p> <p>(one study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/>low<sup>a</sup><sup>,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>580.6 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>343.8 per 1000</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Additional IOP‐lowering procedures required</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>RR 5.81</b> (1.41 to 23.88) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>64.5 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>375 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life measures</b> </p> <p><i>(at 12 months)</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No data available for this outcome</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The <b>assumed risk</b> (e.g. the median control group risk across studies) is based on the estimate in the control group. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IOP:</b> intraocular pressure; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High certainty.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate certainty.</b> Further research is likely to have an important impact on our confidence in the estimate of effect, and may change the estimate.<br/><b>Low certainty.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect, and is likely to change the estimate.<br/><b>Very low certainty.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded for high risk of attrition bias<br/><sup>b</sup>Downgraded one level for imprecision due to wide confidence intervals </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Phacoemulsification versus phacoemulsification plus trabeculectomy for primary angle‐closure glaucoma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD005555-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary table</span></div> <tbody> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Intervention</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comparison</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Laser peripheral iridotomy (LPI)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification plus viscogonioplasty</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification plus goniosynechialysis (phaco‐GSL)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Phacoemulsification plus trabeculectomy</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Trabeculectomy</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0002" title="Azuara-BlancoA , BurrJ , RamsayC , CooperD , FosterPJ , FriedmanDS , et al. Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial. Lancet2016;388(10052):1389-97. Azuara-BlancoA , BurrJM , CochranC , RamsayC , ValeL , FosterP , et al. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial. Trials2011;12:133. ISRCTN44464607. The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle closure glaucoma. isrctn.com/ISRCTN44464607 (first received 22 August 2008). ">Azuara‐Blanco 2016</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0005" title="EslamiY , LatifiG , MoghimiS , GhaffariR , FakhraieG , ZareiR , et al. Effect of adjunctive viscogonioplasty on drainage angle status in cataract surgery: a randomized clinical trial. Clinical and Experimental Ophthalmology2013;41(4):368-78. MoghimiS , LatifiG , ZandVakilN , MohammadiM , KhatibiN , Soltani-MoghadamR , LinS . Phacoemulsification versus combined phacoemulsification and viscogonioplasty in primary angle-closure glaucoma: a randomized clinical trial. Journal of Glaucoma2015;24(8):575-82. [DOI: 10.1097/IJG.0000000000000196]">Moghimi 2015</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0001" title="AngmoD , ShakrawalJ , GuptaB , YadavS , PandeyRM , DadaT . Comparative evaluation of phacoemulsification alone versus phacoemulsification with goniosynechialysisin primary angle-closure glaucoma: a randomized controlled trial. Ophthalmology Glaucoma2019;2(5):346-56. CTRI/2015/05/005742. Role of lens extraction combined with goniosynechialysis versus lens extraction alone in primary angle closure glaucoma. apps.who.int/trialsearch/Trial2.aspx@TrialID=CTRI/2015/05/005742 (accessed 13 December 2019). ">Angmo 2019</a>; <a href="./references#CD005555-bbs2-0004" title="HusainR , DoT , LaiJ , KitnarongN , NongpiurME , PereraSA , et al. Efficacy of phacoemulsification alone vs phacoemulsification with goniosynechialysis in patients with primary angle-closure disease: a randomized clinical trial. JAMA Ophthalmology2019;137(10):1107-13. NCT02376725. Comparing Phaco/IOL versus Phaco/IOL + Goniosynechialysis in subjects with PACG [A randomized clinical trial comparing phacoemulsification and goniosynechialysis with phacoemulsification alone in the management of primary angle closure]. clinicaltrials.gov/ct2/show/NCT02376725 (first received 3 March 2015). TunTA , BaskaranM , PereraSA , HtoonHM , AungT , HusainR . Swept-source optical coherence tomography assessment of iris-trabecular contact after phacoemulsification with or without goniosynechialysis in eyes with primary angle closure glaucoma. British Journal of Ophthalmology2015;99(7):927-31. [DOI: 10.1136/bjophthalmol-2014-306223]">Husain 2019</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0003" title="El SayedYM , ElhusseinyAM , AlbalkiniAS , El SheikhRH , OsmanMA . Mitomycin C-augmented phacotrabeculectomy versus phacoemulsification in primary angle-closure glaucoma: a randomized controlled study. Journal of Glaucoma2019;28(10):911-5. ">El Sayed 2019</a> </p> <p>(Data not presented for <a href="./references#CD005555-bbs2-0006" title="HansapinyoL , ChoyBNK , LaiJSM , ThamCC . Phacoemulsification versus phacotrabeculectomy in primary angle-closure glaucoma with cataract: long-term clinical outcomes. Journal of Glaucoma2020;29(1):15-23. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. Ophthalmology2008;115(12):2167-73. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LiFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(9):119-23. ">Tham 2008</a>; <a href="./references#CD005555-bbs2-0007" title="ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology2009;116(4):725-31. ThamCC , KwongYY , LeungDY , LamSW , LiFC , ChiuTY , et al. Phacoemulsification vs phacotrabeculectomy in chronic angle-closure glaucoma with cataract: complications. Archives of Ophthalmology2010;128(3):303-11. ThamCC , LeungDY , KwongYY , LIFC , LaiJS , LamDS . Effects of phacoemulsification versus combined phaco-trabeculectomy on drainage angle status in primary angle closure glaucoma (PACG). Journal of Glaucoma2010;19(2):119-23. ">Tham 2009</a>) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD005555-bbs2-0008" title="CUHK_CCT00044. A randomized controlled trial to compare lens extraction alone by phacoemulsification versus trabeculectomy alone in the treatment of medically-uncontrolled CACG without visually significant cataract. www2.ccrb.cuhk.edu.hk/registry/public/24 (first received 8 September 2005). ThamCC , KwongYY , BaigN , LeungDY , LiFC , LamDS . Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology2013;120(1):62-7. ">Tham 2013</a> </p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p>Progression of visual field loss </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OR 0.49 (95% CI 0.24 to 0.92) at 6 months;</p> <p>OR 0.35 (95% CI 0.13 to 0.91) at 12 months;</p> <p>OR 0.37 (95% CI 0.17 to 0.82) at 24 months;</p> <p>OR 0.42 (95% CI 0.20 to 0.87) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean change in IOP</b> </p> <p><b>(in mmHg)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.65 mmHg (95% CI ‐3.12 to 1.82) at 6 months;</p> <p>MD ‐0.03 mmHg (95% CI ‐2.34 to 2.32) at 12 months;</p> <p>MD 0.74 mmHg (95% CI ‐1.66 to 3.13) at 24 months;</p> <p>MD 1.04 mmHg (95% CI ‐1.22 to 3.31) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.50 mmHg (95% CI ‐2.64 to 3.64; 91 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.04 mmHg (95% CI ‐0.93 to 0.85; 1 study, 64 eyes) at 6 months;</p> <p>MD ‐0.12 mmHg (95% CI ‐4.72 to 4.48; 1 study, 32 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.50 mmHg (95% CI ‐1.95 to 2.95) at 1 month;</p> <p>MD 0.00 mmHg (95% CI ‐2.36 to 2.36) at 3 months;</p> <p>MD ‐0.30 mmHg (95% CI ‐1.89 to 1.29) at 6 months;</p> <p>MD ‐0.60 mmHg (95% CI ‐1.99 to 0.79) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean change in anterior chamber depth</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Number of medications used to control IOP</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.65 (95% CI ‐0.85 to ‐0.45) at 6 months;</p> <p>MD ‐0.70 (95% CI ‐0.89 to ‐0.51) at 12 months;</p> <p>MD ‐0.73 (95% CI ‐0.94 to ‐0.52) at 24 months;</p> <p>MD ‐0.65 (95% CI ‐0.87 to ‐0.43) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.30 (95% CI ‐0.56 to ‐0.04; 91 eyes) at 6 months;</p> <p>MD ‐0.30 (95% CI ‐0.55 to ‐0.05; 91 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.35 (95% CI ‐0.63 to ‐0.07; 1 study, 64 eyes) at 6 months;</p> <p>MD ‐0.38 (95% CI ‐1.23 to 0.47; 1 study, 32 eyes) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.30 (95% CI 0.01 to 0.59) at 1 month;</p> <p>MD 0.40 (95% CI 0.06 to 0.74) at 3 months;</p> <p>MD 0.20 (95% CI ‐0.15 to 0.55) at 6 months;</p> <p>MD 0.00 (95% CI ‐0.42 to 0.42) at 12 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gonioscopic findings</b> </p> <p><b>(measured in degrees)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Appositional angle closure</i><br/>MD ‐84.93° (95% CI ‐131.25 to ‐38.61) at 12 months; </p> <p>MD ‐74.16° (95% CI ‐121.34 to ‐26.98) at 36 months</p> <p><i>Synechial angle closure</i> </p> <p>MD ‐69.63° (95% CI, ‐104.34 to ‐16.92) at 12 months;</p> <p>MD 1.12 (95% CI, ‐42.37 to 44.62) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Angle width</i><br/>MD ‐0.60 (95% CI ‐0.91 to ‐0.29; 91 eyes) at 12 months or later; </p> <p><i>TISA500</i><br/>MD ‐0.03 (95% CI ‐0.06 to ‐0.01; 91 eyes) at 12 months; </p> <p><i>TISA750</i><br/>MD ‐0.03 (95% CI ‐0.06 to ‐0.01; 91 eyes) at 12 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>AOD500</i><br/>MD ‐0.04 (95% CI ‐0.27 to 0.19; 1 study, 64 eyes); at 6 months; </p> <p><i>AOD750</i><br/>MD 0.01 (95% CI ‐0.27 to 0.29; 1 study, 64 eyes) at 6 months; </p> <p><i>TISA500</i> <br/>MD ‐0.02 (95% CI ‐0.06 to 0.02; 1 study, 64 eyes) at 6 months; </p> <p><i>TISA750</i><br/>MD ‐0.03 (95% CI ‐0.17 to 0.11; 1 study, 64 eyes) at 6 months; </p> <p><i>SSA</i><br/>MD ‐1.59 (95% CI ‐6.75 to 3.57; 1 study, 64 eyes) at 6 months </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Best corrected visual acuity</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 2.03 (95% CI ‐0.77 to 4.84) at 12 months;</p> <p>MD 4.30 (95% CI 0.74 to 7.87) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.01 (95% CI ‐0.10 to 0.08; 91 eyes) postoperatively</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD ‐0.03 (95% CI ‐0.18 to 0.12; 1 study, 63 eyes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to complete analysis to compare between groups</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Adverse effects</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Phacoemulsification group:</i> </p> <p>malignant glaucoma (1 eye);</p> <p>irreversible loss of vision of more than 10 ETDRS letters (1 eye);</p> <p>other related adverse events (1 eye).</p> <p><i>LPI group:</i> </p> <p>lost ten or more ETDRS letters irreversibly (3 eyes);</p> <p>other related adverse events (10 eyes).</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i>Phaco‐GSL group</i> </p> <p>hyphema (3 eyes)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Less risk of:</p> <p>Intra‐ and post‐operative complications (RR 0.59, 95% CI 0.34 to 1.04);</p> <p>additional IOP‐lowering procedures (RR 5.81, 95% CI 1.41 to 23.88) in the phacoemulsification group </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>none</p> </td> </tr> <tr> <th align="left" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of life measures</b> </p> <p><b>(European Quality of Life‐5 Dimension)</b> </p> </th> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.03 (95% CI ‐0.16 to 0.22) at 6 months;</p> <p>MD 0.04 (95% CI ‐0.16 to 0.24) at 12 months;</p> <p>MD 0.005 (95% CI ‐0.19 to 0.20) at 24 months;</p> <p>MD ‐0.04 (95% CI ‐0.24 to 0.16) at 36 months</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><b>AOD:</b> angle opening distance; <b>CI:</b> confidence interval; <b>IOP:</b> Intraocular pressure; <b>NR:</b> not reported; <b>MD:</b> mean difference; <b>OR:</b> odds ratio; <b>RR:</b> risk ratio; <b>SSA:</b> scleral spur angle; <b>TISA:</b> trabecular iris space area </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/full#CD005555-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005555-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Mean IOP change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mean number of medications to control IOP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Gonioscopic findings <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Change of angle grading at 12 months or later</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 TISA500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.3 TISA750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Mean visual acuity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 postoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Phacoemulsification versus phaco‐viscogonioplasty (phaco‐VGP)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005555-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Mean IOP change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Mean number of medications to control IOP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Gonioscopic findings <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 AOD500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 AOD750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 TISA500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.4 TISA750</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.5 SSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Phacoemulsification versus phacoemulsification with goniosynechialysis (phaco‐GSL)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005555-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Phacoemulsification versus combined phaco‐trabeculectomy</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Mean IOP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 at 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.3 at 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.4 at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.5 at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Mean number of medications to control IOP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 at 1 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 at 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.4 at 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.5 at 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Mean visual acuity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 preoperatively</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 at the final follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Adverse effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Intra‐ and post‐operative complications</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Additional IOP‐lowering procedures</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Phacoemulsification versus combined phaco‐trabeculectomy</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005555.pub3/references#CD005555-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005555.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD005555-note-0017">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005555-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005555-note-0016">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD005555-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD005555-note-0011">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD005555-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD005555-note-0010">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD005555-note-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005555-note-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD005555-note-0009">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005555\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005555\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005555\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005555\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005555\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=KUoIaN9D&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005555.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005555.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005555.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005555.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005555.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717184315"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005555.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717184319"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005555.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db1ba58b6936e',t:'MTc0MDcxNzE4NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 